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The larynx has a challenging dual role in the simultaneous regulation of gas flow into and out of 
the lungs while also establishing resistance required for vocal fold vibration in voiced 
communication. Particular challenges may arise when the larynx is required to alter upper airway 
resistance to meet respiratory demands in a way that conflicts with requirements for voice 
production. Little if anything is known about reciprocal relations between these functions, 
particularly under conditions of respiratory abnormality that affect large sectors of the 
population- an estimated 25% of the US population who experience respiratory abnormalities 
and also relies on the larynx for voiced communication.  
In order to address this gap, the current study investigated two specific aims in a single 
within-subjects experiment: Specific Aim 1 (SA1) assessed spontaneous fluctuations in 
phonatory laryngeal resistance during states of (a) induced hypocapnia (low arterial carbon 
dioxide) and (b) induced hypercapnia (high arterial carbon dioxide), in comparison to a eupneic 
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control condition and Specific Aim 2 (SA2) investigated the reciprocal effects of laryngeal 
resistance modulations on respiratory homeostasis.  
Results of the first aim demonstrated that phonatory laryngeal resistance remained stable 
and did not significantly change despite manipulations of inspired gas concentrations causing 
significant increases and decreases in carbon dioxide (CO2) levels. For the second aim, results 
showed that phonation significantly increased levels of end-tidal carbon dioxide (PetCO2) in all 
experimental conditions, compared to PetCO2 levels during rest breathing. Findings provide 
support for a theory of voice motor control suggesting that phonatory laryngeal resistance may 
be an essential, relatively immutable control parameter in phonation (except perhaps under 
extreme conditions not tested herein), and provides data on the influence of phonation on 
respiration. The current work sets the foundation for future studies of laryngeal function during 
phonation in individuals with lower airway disease. 
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1.0  INTRODUCTION 
Examination of the literature reveals an unfortunate divide between research in respiratory 
physiology versus phonatory physiology. Specifically, literature in both domains largely ignores 
the complex relationship between the lower and upper airways for simultaneous goals of 
maintaining blood-gas homeostasis and producing voice. One fairly trivial example is observed 
in the diverse methodology used to measure laryngeal resistance across domains. In respiratory 
physiology, laryngeal resistance is often evaluated during breathing by measures of glottal area 
(Bartlett, 1979; England & Bartlett, 1982; England, Bartlett, & Daubenspeck, 1982; England, 
Bartlett, & Knuth, 1982). In voice science, laryngeal resistance is quantitatively assessed during 
phonation as the ratio of estimated sub-glottal pressure (Psub) to trans-laryngeal airflow 
(Smitheran & Hixon, 1981). It is clear that lower and upper airway functions are critical for both 
ventilation and communication. Relevant for the present study, clinical observations suggest that 
dyspnea (difficulty breathing) and voice problems are common co-morbidities (Hočevar-
Boltežar, Janko, & Žargi, 1998; Hoit, Lansing, & Perona, 2007; Koufman & Blalock, 1988; 
Nguyen, Kenny, Tran, & Livesey, 2009). Regrettably, little information is available about 
potential mechanisms by which abnormal respiration may affect the larynx’s phonatory functions 
and conversely, how laryngeal mechanics during voice production may in turn affect ventilation. 
The current investigation is a second step in a long-range plan investigating the intricate balance 
between respiratory and laryngeal functioning in individuals who both breathe and speak, who 
clearly constitute the vast majority of the population. 
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The long-range research plan involves four stages: (1) identify aerodynamic profiles of 
individuals with Primary Muscle Dysphonia (MTD-1), which is thought to involve phonatory-
respiratory dysregulation; (2) evaluate reciprocal functions of larynx and lower airways with 
respect to blood-gas homeostasis during phonation; (3) identify potential risk factors for voice 
problems such as MTD-1 in individuals with respiratory abnormalities, and identify bio-
behavioral markers connecting them, based on findings from the preceding series; and (4) 
develop a multi-disciplinary evaluation and treatment approach for individuals with co-morbid 
respiratory and voice abnormalities. 
The first of the foregoing issues was addressed by a published, retrospective review of 
aerodynamic data for 90 female patients diagnosed with MTD-1, at their first clinical 
presentation. Results identified several distinct patterns of laryngeal resistance, derived from 
aerodynamic measures discussed shortly. Results also illuminated heterogeneity in the 
aerodynamic features of the disorder and further suggested a possible interaction between 
respiratory and phonatory functions at its center. Finally, results also led to the theoretical 
underpinnings for proposed research phase (2) above, which is the focus of the current 
dissertation. Research phases 3 and 4 are planned for post-doctoral work. 
 
Specific Aims of the current proposal were (SA1): Assess changes in phonatory laryngeal 
resistance during (a) induced hypocapnia (low arterial carbon dioxide) and (b) induced 
hypercapnia (high arterial carbon dioxide), and (SA2): investigate the effects of such changes on 
respiratory homeostasis. Both SAs were addressed in a single, within-subjects experiment, which 
involved manipulation of blood-gas concentrations of CO2 to establish respective states of hypo- 
and hypercapnia in healthy women, during phonation and rest. For SA1 (a) and (b), changes in 
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phonatory laryngeal resistance were assessed as a function of respiratory condition (hypocapnia, 
hypercapnia, and normal “eupneic” breathing). For SA2, changes in end-tidal PCO2 were 
evaluated as a function of laryngeal resistance during rest and phonation in hypocapnic, 
hypercapnic, and eupneic conditions. This project represents a novel convergence of respiratory 
and voice science that expands basic physiologic research, ultimately with direct application for 
individuals with co-morbid breathing and voice problems and individuals at risk for them. 
4 
 
2.0  VOICE PROBLEMS  
Voice disorders are estimated to affect 3-9% of the population at any given moment in time 
(Verdolini & Ramig, 2001). Consequences include communication breakdown, lost income, and 
psychological distress (Verdolini & Ramig, 2001). Voice problems are often divided into two 
broad categories based on suspected etiology: those due to obvious physical pathology, and those 
without a clear organic cause. Unfortunately, problems diagnosed as “non-organic” often involve 
unidentified physical factors. One of the most common putatively “non-organic” conditions is 
primary muscle tension dysphonia (MTD-1). This condition is often diagnosed based on reported 
symptoms in the absence of clear clinical findings (Roy, 2010). Patients with MTD-1 report 
subjective somatic complaints of odynophonia (Koufman & Blalock, 1988; Sapienza, Walton, & 
Murry, 2000), vocal fatigue (Garrett & Cohen, 2008; Nguyen & Kenny, 2009; Nguyen, et al., 
2009; Sapienza, et al., 2000), shortness of breath with speaking, (Nguyen, et al., 2009), cough, 
and throat clearing (Garrett & Cohen, 2008).  
A number of mechanisms are likely responsible for the development of this condition. 
Relevant for the proposed study, clinicians and researchers have noted changes not only in 
laryngeal function with MTD-1, but have also made non-specific assertions about respiratory 
dyscoordination as a foundational element in the development and maintenance of this disorder. 
We now turn to a fuller discussion of MTD-1 and its possible respiratory involvement.   
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2.1 PRIMARY MUSCLE TENSION DYSPHONIA 
Primary MTD (MTD-1) accounts for up to 40-70% of voice clinic caseloads (Angsuwarangsee 
& Morrison, 2002; Roy, 2003), and is most often diagnosed in individuals with substantial 
professional voice demands (Willinger, Volkl-Kernstock, & Aschauer, 2005). The condition has 
been called by many names, including hyper/hypofunctional voice disorder, spastic dysphonia, 
functional dysphonia, psychogenic dysphonia and muscle misuse voice disorder (Aronson, 
Brown, Litin, & Pearson, 1968; Froeschels, 1952; Hillman, Holmberg, Perkell, Walsh, & 
Vaughan, 1989a; Morrison & Rammage, 1993; Roy, 2003; Roy et al., 1997). The wide array of 
diagnostic terminology reflects the challenge in identifying one term for a disorder that presents 
with a considerable variety of patient-reported symptoms as well as subjective and objective 
clinical representations. MTD-1 was once thought to be a vocal manifestation of a 
psychopathology, or a conversion disorder (Aronson, et al., 1968; Kinzl, Biebl, & Rauchegger, 
1988; Millar, Deary, Wilson, & MacKenzie, 1999). Today, it is also attributed to “poor speaking 
or singing technique” (Andrade et al., 2000; Angsuwarangsee & Morrison, 2002; Awan & Roy, 
2009; Koufman & Blalock, 1988; Roy, 2010; Roy & Hendarto, 2005; Sapienza, et al., 2000; Van 
Houtte, Van Lierde, & Claeys, 2010; Vertigan et al., 2006), which may involve some sort of 
generally poorly defined breathing abnormality (Hixon & Putnam, 1983; Rubin, Macdonald, & 
Blake, 2010), for example: “surges of uncontrolled expiratory air” (Morrison & Rammage, 1993, 
p. 431), increased abdominal-thoracic muscle activation (Hočevar-Boltežar, et al., 1998), and 
“inappropriate phonatory habits” (Iwarsson, Thomasson, & Sundberg, 1998, p. 424).  
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2.1.1 Respiratory characteristics of muscle tension dysphonia  
Consistent with the designation of MTD-1 as a laryngeal muscle tension response, intrinsic and 
extrinsic laryngeal muscle tension patterns have been described for this condition for decades 
(Morrison, Rammage, Belisle, Pullan, & Nichol, 1983). However, germane to the present study, 
suggestions have also been made that MTD-1 may be associated with abnormal coordinative 
patterns not only at the laryngeal level, but also across respiratory and laryngeal subsystems of 
phonation. Specifically, according to Morrison and Rammage (1993), individuals with MTD-1 
demonstrate “poor coordination among respiratory, phonatory, resonatory and articulatory 
gestures” (p. 429), “inappropriate muscle tone, disturbed feedback, poor coordination of the 
voluntary muscle system” (p. 430) and “incoordinate breathing such that the larynx functions 
more like a valve, controlling the rate of expiratory airflow” (p. 431). In addition, characteristics 
such as “a lot of respiratory effort in the upper chest” causing a “breath control problem,” 
(Morrison, 1997, p. 110) and “undesirable speech breathing habits” (Hixon & Hoit, 2005, p. 113) 
have been attributed to individuals with MTD-1. Despite such claims, the literature lacks clear 
physiologic descriptions of presumed respiratory/phonatory disruptions in MTD-1, as well as a 
lack of theoretical discourse on why or how these disruptions may develop. Moreover, numerous 
studies of MTD-1 ignore its potential respiratory component, focusing instead on laryngeal 
factors alone (Hočevar-Boltežar, et al., 1998; Morrison, Nichol, & Rammage, 1986; Roy, Bless, 
Heisey, & Ford, 1997; Sama, Carding, Price, Kelly, & Wilson, 2001; Sapienza, et al., 2000; 
Stager, Bielamowicz, Regnell, Gupta, & Barkmeier, 2000).  
 The specific patterns of laryngeal muscle activity in people with MTD-1 have been 
studied with inconclusive results. In general, studies of laryngeal muscle activity have focused 
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solely on the muscle activation patterns of the extrinsic laryngeal muscles, overlooking the role 
of subglottic and respiratory functions in phonation. In such studies, the assumption seems to be 
that this voice disorder occurs due to “tension” at the level of the glottis or supraglottis (Hočevar-
Boltežar, et al., 1998). However, studies of the chest wall (abdominal and thoracic) musculature 
have found increased or abnormal activity in these muscles as well as in the larynx, indicating 
the potential contribution of respiratory factors in the condition (Hočevar-Boltežar, et al., 1998; 
Rubin, et al., 2010). Respiratory-laryngeal coordination has been investigated by other authors as 
well (for example, Hixon & Putnam, 1983; Iwarsson, 2001; Morrison & Rammage, 1993; Stone, 
1993). Those studies have revealed a trend indicating individuals with MTD-1 tend to phonate in 
lower lung volume ranges (45-10% of vital capacity) than typical (60-40% of vital capacity). In 
addition, reports have indicated that in MTD-1, muscular forces in the rib cage/thoracic cavity 
work in opposition to the abdominal musculature, creating co-contraction and a tightly held 
thoracic-abdominal wall. In these instances, the respiratory-laryngeal interaction could be 
described as inefficient, contributing to MTD-1 (Hixon & Putnam, 1983). However, it can be 
argued that in some instances, abdominal-thoracic co-contraction can be beneficial or even 
normal, as for example, for core stabilization and to provide expiratory checking to prevent rapid 
loss of inspired air at high lung volumes, or to assist in expiration in obstructive pulmonary 
diseases such as asthma and chronic obstructive pulmonary disease (Braman, 2007)  . 
Another approach to address issues of respiratory-phonatory coordination in phonation 
was described in a seminal study by Hillman and colleagues over 20 years ago (Hillman, et al., 
1989a). These authors described a conceptual continuum to distinguish “adducted” versus “non-
adducted hyperfunction.”  The proposal was that adducted vocal hyperfunction involves vocal 
fold “tension,” increased subglottal pressure, and increased vocal fold impact stress, raising the 
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risk of phonotraumatic vocal fold injury. In contrast, in non-adducted hyperfunction, achieved 
with tensed but non-adducted vocal folds, the potential for mucosal trauma would be reduced. 
However, phonatory subglottal pressures would be increased to initiate and maintain phonation, 
and increased (turbulent) airflow might occur as a result of the “valve leak.” Laryngeal resistance 
data based on 15 patients with vocal fold lesions and “functional dysphonia” (essentially MTD-
1) were generally consistent with the proposed framework.  
As an attempt to replicate and expand upon Hillman and colleagues’ work, a pre-
dissertation research study that was a precursor to the present dissertation compared the 
aerodynamic profiles of 90 adult females diagnosed with MTD-1 to normative aerodynamic data 
published elsewhere (Holmberg, Hillman, & Perkell, 1988). In concordance with Hillman’s 
results, on average the patient group demonstrated significantly higher average estimated 
subglottal pressure (Psub) and phonatory airflow rates than the control means (Gillespie, Gartner-
Schmidt, Rubinstein, & Verdolini Abbott, 2012). The data were then further examined in terms 
of all possible permutations of aerodynamic profiles, specifically, in terms of patterns of 
subglottal pressure (cmH20) and phonatory airflow (L/sec) relations. Results are shown in  
 
 
 
 
Table 2.1. Nine data patterns were theoretically possible. However, only five distinct 
patterns were identified in the data set. The clusters were created based on commonalities in 
member data. For each cluster, members had less variability around the airflow data than the 
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pressure data. Therefore, cluster formation was more dependent on airflow than Psub. In other 
words, more subjects’ data fell into a cluster based on similarities in airflow than in Psub. 
 
 
 
 
 
Table 2.1. Permutations of Aerodynamic Profiles of Females with MTD-1 
Rank of the cluster 
by % of total 
sample size. 
Pattern Percent of total 
sample 
1 Airflow: normal 
Psub: normal 
32.3% (n=29) 
2 Airflow: high 
Psub: high 
20.0% (n=18) 
3 Airflow: low 
Psub: normal 
18.9% (n=17) 
4 Airflow: normal 
Psub: high 
17.8% (n= 16) 
5 Airflow: high 
Psub: normal 
11.1% (n=10) 
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Airflow: normal 
Psub: low 
0% (n=0) 
7 Airflow: low 
Psub: low 
0% (n=0) 
8 Airflow: low 
Psub: high 
0% (n=0) 
9 Airflow: high 
Psub: low 
0% (n=0) 
 
These data expand on data reported by Hillman et al (Hillman, et al., 1989a). The prior 
authors identified three of the five patterns that we found: pattern 2 (high flow/high Psub), pattern 
4 (normal flow/high Psub), and pattern 5 (high flow/normal Psub). The variety of aerodynamic 
profiles of individuals with MTD-1 indicates that at least conceptually, multiple mechanisms of 
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respiratory and laryngeal dysfunction may be involved in the condition (Gillespie, et al., 2012). 
Why and how the dysfunction or dyscoordination begins is still unknown, and is the focus of the 
current study. Also unknown are mechanisms of interactions across respiratory and phonatory 
systems. A review of respiratory physiology, in particular its relation to voice production, 
follows next.  
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3.0  RESPIRATORY PHYSIOLOGY 
At the most basic level, respiratory functions can be described in terms of interactive processes 
across cardiovascular and pulmonary systems. In the heart, the right ventricle pumps 
metabolically produced, carbon dioxide (CO2)-rich blood into the lungs, which is then exhaled 
back into the atmosphere (Hlastala & Berger, 2001). Each inspiration brings oxygen (O2) rich air 
into the lungs, replacing the expired CO2. This highly oxygenated blood leaves the lungs via the 
left pulmonary veins to the left atrium, and is distributed to body tissues by way of the 
bloodstream (Levitzky, 1995).  
3.1 GAS EXCHANGE 
The primary role of the human respiratory system is to deliver O2 to the tissues of the body to 
meet metabolic tissue demands, using the least amount of energy expended.  A second major role 
is to remove CO2 by-products of cellular metabolism (Hlastala & Berger, 2001). The 
cardiovascular and respiratory systems work together to modulate respiratory frequency to meet 
the body’s metabolic needs (Hlastala & Berger, 2001). Increasing CO2 levels produced by the  
tissues cause an increase in H+ (hydrogen ion) concentration and an increase in pH level in 
arterial blood gas concentrations. One way that homeostatic acid-base balance and pH regulation 
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is achieved is via removal of CO2 from the body in ventilation. If blood becomes too acidic (pH 
decreases), respiratory rate increases to rid the body of more CO2, freeing fewer hydrogen ions, 
resulting in an increase in pH to normal levels. 
The earth’s atmosphere is 78.08% nitrogen, 20.95% oxygen, .04% carbon dioxide, and 
.93% argon (Hlastala & Berger, 2001). Each inspiration brings in approximately 350mL of air 
containing approximately 21% O2, and each expiration releases 350mL of air containing 
approximately 5-6% CO2. Typically, 250mL of CO2/minute diffuses from the blood supply into 
the alveoli, and 300mL of O2 diffuses from the alveoli into the blood supply (pulmonary 
capillaries) per minute (Levitzky, 1995). The partial pressure of a gas equals its “fractional 
concentration times the total pressure of all the gases in the mixture” (Levitzky, 1995). The 
prefix “P” refers to the partial pressure of a gas (e.g. PO2 indicates the partial pressure of 
oxygen). Measuring the amount of CO2 or O2 at the end of a tidal exhalation (end-tidal) is 
equivalent to measuring arterial CO2 or O2. The partial pressure of CO2 expired at the end of a 
normal tidal expiration is referred to as end-tidal CO2 or PetCO2 (Levitzky, 1995). Alveolar PO2 
increases 2-4 mmHg per normal inspiration, and slowly decreases until the next inspiration. 
Alveolar PCO2 falls 2-4 mmHg/inspiration and increases slowly until the next inspiration when 
it falls again (Levitzky, 1995). The levels of a gas in arterial circulation are determined by any 
processes affecting alveolar ventilation, the pH of blood, the body’s need for O2 consumption in 
the tissues, and CO2 production as a by-product of cellular metabolism (Levitzky, 1995). As 
alveolar ventilation increases, alveolar PCO2 decreases.  
The normal partial pressure of arterial CO2 ranges between 35-45 mmHg. CO2 levels 
below 35 mmHg indicate hypocapnia; above 45 mmHg denote hypercapnia (Zvolensky & Eifert, 
2001). In healthy humans, imbalances of O2 and CO2 are responded to with changes in 
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ventilatory depth and frequency. The respiratory response to hypercapnia is an increase in 
breathing frequency and depth in order to rid the body of the excess CO2 to prevent a decrease in 
blood pH below 7.3, or acidosis (Wilmore, Costill, & Kennedy, 2008; Zvolensky & Eifert, 
2001). However, if the increase in respiratory frequency leads to unchecked hypocapnia, 
alkalosis may occur, and with it, a pH elevation above the normal range of 7.35-7.45 (Sikter, 
Faludi, & Rihmer, 2009; Zvolensky & Eifert, 2001). The typical response to hypocapnia is 
therefore a decrease in respiratory rate and depth. Changing CO2 levels exert the greatest 
influence over the nervous system’s control of ventilation.  Even a small increase in arterial CO2 
can cause a marked increase in ventilation, as mediated by central chemoreceptors (Rassovsky, 
Abrams, & Kushner, 2006). 
 
3.2 NEURAL CONTROL OF BREATHING 
Respiration is regulated by a dual control system - both voluntary (for speech, singing, 
swimming, etc.) and involuntary (life sustaining). In both voluntary and involuntary ventilation, 
every breath must be initiated by the brain. The respiratory control center resides in the medulla 
of the brainstem. Both peripheral and central chemoreceptors sense changes in the local chemical 
environment and send afferent information to the medulla to trigger a ventilatory response to 
alter the body’s balance of CO2, O2, and pH (Levitzky, 1995).  
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3.2.1 Central chemoreceptors. 
Central chemoreceptors are located on the anterolateral surface of the medulla, near the 4th 
ventricle (Hixon & Hoit, 2005). These central receptors do not come into contact with the blood 
supply, but sense chemical changes in cerebrospinal fluid (CSF) (Levitzky, 1995). Receptors 
respond to fluctuations in Hydrogen (H+) and CO2, but not to changing levels of O2 (Levitzky, 
1995; Pain, Biddle, & Tiller, 1988; Smith, Rodman, Chenuel, Henderson, & Dempsey, 2006; 
Zvolensky & Eifert, 2001). Hydrogen changes, which reflect PCO2 changes, are sensed more 
rapidly in the pH of the CSF than in the arterial blood supply (Smith, et al., 2006). Arterial 
hypercapnia (increased PCO2 in the blood supply) causes a greater change in CSF H+ ion 
concentration than the H+ ions in the arterial blood. This change in H+ is then sensed by the 
central chemoreceptors. A decrease in arterial PCO2 (hypocapnia), causes an increase in the pH 
of cerebral spinal fluid, and a decrease in central chemoreceptor stimulation (Levitzky, 1995).  
3.2.2 Peripheral chemoreceptors. 
Peripheral chemoreceptors are nerve endings in the carotid bodies (in the bilateral common 
carotid arteries) and in the aortic bodies (in the arch of the aorta) (Hlastala & Berger, 2001). 
Carotid body receptors are considered more efficient than aortic bodies in sensing blood-gas 
changes. The carotid bodies are primarily responsible for responses to hypoxia (decrease in O2), 
and play a smaller role in sensing and responding to increases in arterial CO2 and decreases in 
arterial pH (Atwood, 2010; Hlastala & Berger, 2001; Levitzky, 1995; Smith, et al., 2006; 
Zvolensky & Eifert, 2001). Hering’s nerve, a branch of the glossopharyngeal nerves, and the 
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vagus nerves, carry afferent information from the carotid and aortic bodies respectively to the 
central nervous system. Relevant to the current investigation, the only laryngeal abductor, the 
posterior cricoarytenoid muscle, may receive carotid chemoreceptor mediated inhibitory input 
from the vagus nerve, decreasing the amount of expiratory laryngeal resistance in hypercapnic 
conditions (England, Bartlett, & Knuth, 1982).    
3.2.3 Respiratory responses to changing blood-gas levels. 
The respiratory system is uniquely designed to rapidly respond to a variety of physical, chemical, 
and cognitive stimuli via increases and decreases in ventilatory frequency. The central 
chemoreceptor detection of changing CO2 is crucial to the central and peripheral control of 
breathing. PCO2 is low when ventilation is increased, and PCO2 is high when ventilation is 
decreased. Minute ventilation (VE) (the amount of air entering and leaving the body per minute) 
increases with increasing amounts of CO2 in inspired air. This effect is most pronounced when 
inspired CO2 equals 5-10% of the total gas mixture (CO2 typically makes up .03% of 
atmospheric content) (Levitzky, 1995). Inhaling 5-10% CO2 causes an increase in alveolar PCO2 
between 40-70 torr. At this level, the ventilatory response to increasing CO2 is linear. 
Concentrations of CO2 of 10-15% of inspired air cause additional symptoms beyond increased 
minute ventilation such as dyspnea, headaches, restlessness, faintness, and cognitive effects. 
When CO2 reaches levels greater than 15% in inspired air, unconsciousness, rigidity and tremors 
are observed. Increasing levels of CO2 in the lung causes an increase in alveolar ventilation 
which decreases alveolar (and arterial) PCO2 to return the body to blood-gas homeostasis. 
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Severely elevated PCO2 can cause respiratory depression. Chronic hypercapnia can cause 
chronic elevations in pH and a less sensitive ventilator response in acute hypercapnic situations.  
3.2.4 Respiratory responses to cognitive stimuli. 
Non-metabolic respiration, or respiration for speech and emotional expression among other 
voluntary acts, is mediated by high cortical areas (Hixon & Hoit, 2005). The primary motor 
cortex, premotor cortex, and supplemental motor area of the frontal lobe, and somatosensory area 
in the parietal lobe, are all involved in the control of volitional respiration. Structures in the 
limbic lobe, a phylogenetically older region of the cerebral cortex, are responsible for 
involuntary respiratory changes due to emotional contexts (Hixon & Hoit, 2005). Some “typical” 
emotional respiratory responses such as gasping, breath holding when scared, laughing, and 
crying, are regulated from centers in the hypothalamus (Marieb, 2002). When an individual 
experiences stress in circumstances requiring phonation, as may occur in stage fright in public 
speaking or singing, the nervous system has to simultaneously maintain metabolic homeostasis, 
support the intended communicative output, and overcome the adverse limbic influence (Hixon 
& Hoit, 2005). Voluntary breath holding will eventually induce a chemical drive to breathe (by 
inducing high PCO2, low PO2, and low pH) (Levitzky, 1995).  
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3.3 ABNORMAL BLOOD-GAS LEVELS IN PULMONARY AND 
PSYCHOLOGICAL DISORDERS 
Of interest for the present argument, individuals with anxiety disorders are thought to be more 
sensitive to PCO2 fluctuations than healthy controls. Those with panic disorder are especially 
susceptible. A panic attack can be triggered by small increases in PCO2, which in turn trigger an 
increase in ventilation (hyperventilation), which then reduces PCO2. This ventilatory response is 
known as an individual’s CO2 sensitivity (Zvolensky & Eifert, 2001). In addition, individuals 
with high trait anxiety have been observed to have shorter expiratory phases in respiration, 
reduced or erratic tidal volumes, and chronically decreased end-tidal PCO2 levels compared to 
those with low trait anxiety (Bass & Gardner, 1985a; Masaoka & Homma, 2001). These 
characteristics are amplified in situations causing anticipatory anxiety, and during stress-
inducing tasks (Masaoka & Homma, 2001).  
Even more relevant to the greater public health is the prevalence of respiratory disorders 
in the population. More than 10% of the US population suffers from a chronic respiratory 
condition such as asthma or chronic obstructive pulmonary disease (COPD) (Kunik et al., 2005). 
These obstructive disorders are the second leading reason, behind heart disease, that people seek 
disability benefits (West, 1995). Both asthma and COPD, particularly when untreated, can cause 
chronic states of hyperventilation resulting in hypocapnia (Braman, 2007). Hypercapnia is also 
an etiologic factor in the pervasive dyspnea experienced by individuals with pulmonary, cardiac, 
and neurologic disease (Hoit, et al., 2007). Dyspnea during speech is a common complaint, with 
up to a third of individuals with COPD complaining of speaking-related dyspnea (Hoit, et al., 
2007). Dyspnea in speech has been perceived as worse than dyspnea during rest breathing (Hoit, 
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et al., 2007). One reason for this complaint is a presumed competition between the respiratory 
needs of the speech mechanism, and those of the lower airway (Hoit, et al., 2007). 
Anxiety, depression, and panic disorder are common co-morbidities in pulmonary 
disorders (Bass, 1997; Dratcu, 2000; Goodwin & Pine, 2002; Kunik, et al., 2005). Rates of panic 
disorder in patients with COPD are three times higher than panic disorder rates in the general 
population (Dratcu, 2000). Anxiety is also common in these individuals, estimated at 34-50% 
(Kunik, et al., 2005). In addition, and germane to the present proposal, co-morbidity of 
dysphonia and lower airway disease such as asthma is also common (Cohen, 2010; England, Ho, 
& Zamel, 1985; Hackenberg, Hacki, Hagen, & Kleinsasser, 2010; Stanton, Sellars, Mackenzie, 
McConnachie, & Bucknall, 2009), with estimates ranging from 25%-50% of people with 
pulmonary disease also experiencing voice problems (Cohen, 2010; Hone et al., 1996; Lavy, 
Wood, Rubin, & Harries, 2000).  
As many as 38% of patients with “functional dysphonia” (a common synonym for MTD-
1 as noted in 2.1) have asthma (Schalen, Andersson, & Eliasson, 1992). In addition, a 
significantly greater number of patients have dysphonia and lung disease than have dysphonia 
and no lung disease (Cohen, 2010). Co-morbid asthma and voice problems affect children as 
well, with some estimates revealing 7% of children with confirmed asthma are dysphonic 
(Carding, Roulstone, & Northstone, 2006). Of import, in many cases, dysphonia cannot be 
attributed to laryngeal mucosal changes from inhaled corticosteroids- a common treatment for 
asthma (Hone, et al., 1996; Lavy, et al., 2000). Individuals with asthma demonstrate reduced 
maximum phonation time, increased noise to harmonic ratio, and perceptually dysphonic voices 
when compared to non-asthmatic speakers (Dogan, Eryuksel, Kocak, Celikel, & Sehitoglu, 
2007). Laryngeal resistance during expiration is increased compared to baseline breathing during 
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bronchoconstriction (both experimentally induced and as a result of spontaneous asthma attack) 
and in individuals with chronic obstructive lung diseases (England, et al., 1985; Shindoh, 
Sekizawa, Hida, Sasaki, & Takishima, 1985).  This increased resistance is thought to aid in 
hyperinflation of the lower airways, preventing further alveolar collapse (Shindoh, et al., 1985). 
In summary, pulmonary disease, psychological illnesses, and voice problems are common co-
morbidities. The next chapter addresses the role of the larynx in the respiratory system.  
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4.0  LARYNGEAL RESISTANCE 
The first studies of laryngeal airway resistance during phonation (Rlaw) in voice and speech 
science were conducted in the 1960s. Investigation of Rlaw was then considered a “pedestrian 
activity” (p. 5) necessary to better understand the details of vocal fold oscillation (Campbell, 
Murtagh, & Raber, 1963). At the time, Rlaw was studied using a rudimentary model of plaster 
casts of the human larynx with metal rectangular slits of known dimensions serving as the glottis 
(Campbell, et al., 1963). In this chapter we will discuss laryngeal resistance as it is understood 
from the standpoints of both respiratory physiology and phonatory science. 
4.1 BASIC CONCEPTS 
Physical resistance refers to an opposition to flow. Laryngeal resistance is the opposition to air 
flowing into or out of the lower airways. In the respiratory physiology literature, laryngeal 
resistance is traditionally measured by calculating glottal area in the absence of phonation (1983; 
England & Bartlett, 1982; Kuna, McCarthy, & Smickley, 1993).  In the voice science literature, 
laryngeal airway resistance (Rlaw) is generally calculated as subglottal pressure (in centimeters of 
water) divided by glottal flow (in liters per second) during phonation. Originally, Rlaw was 
measured with invasive procedures such as tracheal puncture, or using cumbersome equipment 
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such as full body plethysmography (for example, Murry, 1971; Savard, Cole, Miljeteig, & 
Haight, 1993). Non-invasive technology has allowed for estimations of Rlaw relatively non-
invasively during phonation (Hillman, Holmberg, Perkell, Walsh, & Vaughan, 1989b; Ma et al., 
2007; Rothenberg, 1977). These methods, their development and implementation, are the focus 
of this chapter.  
4.2 LARYNGEAL RESISTANCE IN VOICE PHYSIOLOGY 
4.2.1 Measurement of laryngeal resistance  
Phonatory laryngeal airway resistance (Rlaw) in humans was first measured in the 1960s 
(Campbell, et al., 1963). At the start of the 1970s, Murry measured laryngeal resistance 
associated with various laryngeal configurations during voicing (1971). Specifically, he 
measured subglottal pressure (Psub) directly below the vocal folds via tracheal puncture, along 
with simultaneous expired airflow at the mouth, during the production of sustained vowels across 
the pitch range. Psub was greater during productions of vocal fry than in modal pitch, and in 
general decreased as subjects progressed from fry to modal, with the greatest decrease observed 
at 30% of the modal pitch range. Airflow was lower during fry than at modal pitches. The author 
concluded that high Psub and low airflow observed during vocal fry was due to the long closed 
phase in fry with reduced glottal opening (Murry, 1971). A related finding was observed in a pre-
dissertation research study of Psub (estimated via oral pressure during voiceless stops) and airflow 
in females with MTD-1 (Gillespie, et al., 2012). In that study, 18.9% of subjects had low airflow 
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with normal Psub, and 17.8% had normal airflow and high Psub. Stated differently, 36.7% of 
patients diagnosed with MTD-1 demonstrated pressure/flow relations skewed in the direction of 
high Psub compared to flow, qualitatively similar to findings reported by Murry for vocal fry 
(1971). 
A less invasive method of gathering Rlaw data was developed by Smitheran and Hixon in 
1981. The protocol for collecting Rlaw was as follows.  The subject sits with a facemask over the 
nose and mouth, with a thin pressure tube placed between the lips in the oral cavity.  The subject 
is then asked to produce a stop consonant-vowel syllable (e.g. /pa/, /pi/, or /pae/) five times, 
smoothly, at a rate of approximately 1.5 repetitions/second, phonating at a constant comfortable 
pitch and intensity level. The theoretical basis for the task is that oral pressure during a stop 
consonant should approximately reflect phonatory subglottal pressure during subsequent vowel 
phonation, which is the phonatory target of interest. The vowel following the stop consonant is 
selected based on observations that vowels without lip rounding are least likely to interfere with 
the seal between mask and face  (Smitheran & Hixon, 1981). The production rate of 1.5 
syllables/second was suggested by a validity study reported by Holmberg and colleagues 
(Holmberg, Perkell, & Hillman, 1987). This method of collecting Rlaw data has been well vetted 
in the literature, and is the method used in the current investigation. 
 
4.2.2 Laryngeal airway resistance in populations with voice disorders 
In the 1980s, Netsell and colleagues suggested that “to understand complicated voice 
disorders…..quantitative evaluation at all levels of the ‘speech production chain’ is required.” 
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(Netsell, Lotz, & Shaughnessy, 1984, p. 397). This author group, using methods developed by 
Smitheran and Hixon described above (1981), studied the laryngeal resistance of 18 individuals 
with vocal fold lesions and neurologic voice problems and compared the results to those for 30 
normal speakers. Findings indicated that specific voice disorders were not associated with 
specific Rlaw ratios, but that each patient had at least one measure (either pressure, flow, or both) 
outside the normal range. With few exceptions, other authors have similarly found that many, but 
not all, patients with voice problems exhibit values outside the norm for these parameters 
(Gillespie, et al., 2012; Higgins, Chait, & Schulte, 1999; Hillman, et al., 1989b; Ma, et al., 2007).  
4.3 RELIABILITY AND VALIDITY OF LARYNGEAL RESISTANCE MEASURES 
According to at least one study, phonatory laryngeal resistance values in typical females (without 
voice, hearing, or neurologic disorders) obtained over two days at multiple time points were not 
statistically significantly different (Leeper & Graves, 1984). The individual factors that 
determine laryngeal resistance, estimated subglottal pressure and transglottal airflow, also do not 
change significantly across the same time points. Changes in intensity caused the variability in 
laryngeal resistance, whereas resistance was fairly insensitive to fundamental frequency changes. 
When intensity was controlled for, resistance variability decreased compared to the uncontrolled 
condition (Leeper & Graves, 1984). Finally, the effects of auditory perturbations on phonatory 
laryngeal resistance have shown resistance remains stable in healthy speakers using normal or 
resonant voice, with and without auditory masking (Grillo & Verdolini, 2007). The effects of 
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lower airway perturbations on the stability of laryngeal resistance during phonation have not 
been tested and are the focus of the current investigation. 
4.4 LARYNGEAL RESISTANCE IN THE ABSENCE OF PHONATION 
During normal tidal breathing, the upper airway provides 25-60% of overall respiratory 
resistance (England, Bartlett, & Daubenspeck, 1982; Levitzky, 1995; Savard, et al., 1993). The 
larynx is an important factor in the determination of respiratory resistance, airflow volume, and 
rate of breathing. During inspiration for tidal breathing, the glottal opening is wide, providing 
low resistance. For tidal expiration, the vocal folds move slightly towards midline, and resistance 
increases marginally compared to inspiration (Bartlett, 1979; Brancatisano, Dodd, & Engel, 
1991; England, Bartlett, & Daubenspeck, 1982). 
 
4.4.1 Laryngeal resistance across breathing conditions 
Relevant for laryngeal ab- and adductory gestures in breathing, abduction is primarily 
accomplished by the posterior cricoarytenoid (PCA) muscle, and the thyroarytenoid (TA), lateral 
cricoarytenoid (LCA), cricothyroid (CT), and interarytenoid (IA) muscles all play varying 
adductory roles.  
In hypercapnic conditions (high CO2) without phonation, laryngeal resistance during 
breathing, (historically determined by calculation of the distance between the vocal processes 
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and the anterior-posterior vocal fold length as measured from a still image; intrinsic laryngeal 
muscle electromyography; and also by calculation of subglottal pressure divided by laryngeal 
airflow), decreases in both inspiratory and expiratory phases of the cycle, as a function of 
substantial increase in PCA muscle activation, presumably to allow an increase in airflow to 
release more CO2 and inspire more O2 (Bartlett, 1979; Brancatisano, et al., 1991; England & 
Bartlett, 1982). An increase in laryngeal resistance during breathing in both inspiration and 
expiration in hypocapnia (low CO2) has been observed (Bartlett, 1979; Kuna, McCarthy, et al., 
1993). In hyperventilation-induced hypocapnia in mechanically ventilated patients, the PCA has 
shown to cease fire, and the laryngeal adductors increase activation, resulting in vocal fold 
adduction (Kuna, Insalaco, Villeponteaux, Vanoye, & Smickley, 1993). This mechanism of 
action is presumed to assist in CO2 retention and maintenance of alveolar inflation. However, in 
awake patients, hyperventilation, with and without hypocapnia, has shown to have the opposite 
effect of decreasing laryngeal resistance and increasing PCA activity (Bartlett & Knuth, 1984; 
Savard, et al., 1993). In these studies, the laryngeal response to hyperventilation was thought to 
override the laryngeal response to decreasing CO2.  
Despite changing resistance as a function of level of CO2, inspiratory resistance is 
typically lower than expiratory resistance (Bartlett, 1979; Savard, et al., 1993). Animal and 
human studies have shown great variability in raw laryngeal resistance during breathing between 
subjects, but trends in resistance increases and decreases are stable within and between subjects 
(Bartlett, 1979; Savard, et al., 1993) (Table 4.1). 
Respiratory laryngeal resistance in humans with airway disease is particularly relevant to 
the current investigation. Laryngeal resistance during breathing increases with increasing lower 
airway resistance, as is experienced, for example, with bronchoconstriction during asthma attack 
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(England, et al., 1985). Data on respiratory laryngeal resistance in response to lower airway 
perturbations in patients with respiratory disease are mixed, with some reports indicating an 
increase in resistance after methacholine challenge, for example, and others reporting no 
laryngeal change with induced provocations, but an increase in resistance during breathing with 
spontaneous asthma attack (Shindoh, et al., 1985; Yanai, Ohrui, Sekizawa, Sasaki, & Takishima, 
1989). One explanation for conflicting results may lie with the hypothesized mechanisms by 
which the larynx is affected by lower airway perturbations- whether induced or spontaneous. It is 
hypothesized that glottal narrowing is an efferent response to chemicals released during an 
asthma attack which stimulate laryngeal afferents (Shindoh, et al., 1985). Furthermore, as levels 
of CO2 rise in respiratory disease, carotid chemoreceptors -- the primary respiratory sensory 
mechanisms for alterations in arterial blood-gas levels -- may cause an increase in inhibition of 
the abductor posterior cricoarytenoid, thereby reducing glottal width and increasing laryngeal 
resistance in breathing under respiratory disease (England, et al., 1985). In addition, an increase 
in laryngeal resistance during breathing may occur as a laryngeal compensation to the 
constriction of the lower airways (England, et al., 1985; Shindoh, et al., 1985). The “braking” of 
expired air, which occurs from increasing laryngeal resistance, increases lung volume and 
expands the lower airways, assisting in hyperinflation and combating bronchoconstriction 
(England, et al., 1985).  
Alteration of upper airway resistance and limiting chest wall movement affect laryngeal 
resistance during respiration. Breathing against external resistance of airflow as well as with a 
mechanically constricted chest wall cause a decrease in respiratory laryngeal resistance 
(Sekizawa, Yanai, Sasaki, & Takishima, 1986).  In addition, an increase in lower airway 
resistance, often as a result of disease-induced bronchoconstriction or obstruction, results in an 
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increase in laryngeal resistance during rest breathing (England, et al., 1985; Higenbottam, 1980; 
Higenbottam & Payne, 1982; Shindoh, et al., 1985). Table 4.1 details the change in respiratory 
rate and upper airway resistance as a result of blood-gas fluctuations. 
 
Table 4.1. Upper Airway Response to Changing Blood-Gas Concentrations 
Condition Respiratory rate 
response 
Laryngeal/upper 
airway response 
Hypoxia Increased ventilation Upper airway dilation, 
decreased laryngeal 
resistance 
Hypercapnia Increased ventilation  Decreased laryngeal 
resistance 
Hypocapnia Decreased ventilation Increased laryngeal 
resistance 
Homeostasis Eupnea Low laryngeal resistance 
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5.0  SUMMARY AND HYPOTHESES 
 
The larynx is responsible for the control of gas flow into and out of the lungs for dual purposes 
of ventilation and voice production. In ventilation, the airways’ primary function is to maintain 
homeostasis between O2 and CO2 levels in arterial blood (Hixon & Hoit, 2005; Levitzky, 1995). 
In healthy humans, gas imbalances are addressed with changes in respiratory volume and 
frequency. In normal tidal breathing (eupnea), laryngeal resistance decreases during inspiration 
and increases during expiration (Bartlett, 1979; Brancatisano, et al., 1991; England, Bartlett, & 
Knuth, 1982). In hypercapnia (increased CO2), resistance decreases in both inspiratory and 
expiratory phases of the cycle, thereby facilitating intake of O2 and release of CO2 (Bartlett, 
1979; Brancatisano, et al., 1991; England & Bartlett, 1982). Conversely, in hypocapnia 
(decreased CO2), resistance is increased during both inspiration and expiration, facilitating CO2 
retention (Bartlett, 1979; Kuna, McCarthy, et al., 1993) (Table 5.1). Laryngeal airway resistance 
is also increased in conditions of increased lower airway resistance, for example, during 
bronchoconstriction, likely in attempt to assist in alveolar inflation to counteract the constriction 
(England, et al., 1985; Higenbottam, 1980; Higenbottam & Payne, 1982). Table 5.1 details the 
ventilation rate and laryngeal resistance response to changing levels of CO2. It is important to 
note that while ventilation rate and laryngeal resistance respond to CO2 changes (as noted in 
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Table 5.1), these factors also reciprocally alter CO2 levels. For example, increasing ventilation 
beyond the body’s metabolic needs (i.e. hyperventilation) reduces CO2. Increasing laryngeal 
resistance can also increase CO2.  
 
Table 5.1. Upper Airway Resistance Response to Blood-Gas Levels 
 
 
 
 
 
 
Of significance is that both hypo- and hypercapnia are clinically common. Abnormal 
levels of arterial CO2 are observed in individuals with a wide range of clinical disorders, 
including respiratory disorders (e.g., asthma, Chronic Obstructive Pulmonary Disease [COPD], 
and hypoventilation syndrome) (Bass, 1997; Brown, 2010; Devriese et al., 2000; Hoit, et al., 
2007), psychological disorders (Generalized Anxiety Disorder and Panic Disorder) (Bass & 
Gardner, 1985b; Houtveen, Rietveld, & de Geus, 2003; Wientjes & Grossman, 1994), somatic 
illnesses (chronic fatigue syndrome, multiple chemical sensitivity, and functional gastrointestinal 
disorders) (Bass, 1997; Devriese, et al., 2000), neuromuscular disorders (e.g. multiple sclerosis, 
Guillain-Barré, amyotrophic lateral sclerosis), and chest wall disorders (kyphoscoliosis, 
spondylitis, and fibrothorax) (Brown, 2010; Hoit, et al., 2007). Pathologic levels of CO2 
experienced by patient groups are shown in Table 5.2.  
 
 
 
Condition Ventilation 
Rate 
Laryngeal Resistance 
Hypercapnia Increased Decreased 
Hypocapnia Decreased Increased 
Eupnea Tidal Baseline 
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Table 5.2. Arterial CO2 Levels in Patient Groups 
 
 
 
 
 
 
 
 
 
In addition to the larynx’s role as gateway in gas exchange during ventilation, in 
phonation the larynx serves as an oscillator that modulates pulmonary airflows, transforming 
them into systematic acoustic air columns propelled into the vocal tract, which in turn exert 
upstream effects onto vocal fold oscillation itself (Titze, 1988). For voice, phonatory laryngeal 
resistance is calculated as the ratio of subglottic pressure in cmH2O to laryngeal airflow in L/sec 
(Smitheran & Hixon, 1981). The present study was motivated by the observation that although 
the larynx has indisputably critical functions for both respiration and phonation, until now the 
reciprocal relations between these functions has only been minimally investigated (Bartlett, 
1979; England & Bartlett, 1982; England, Bartlett, & Daubenspeck, 1982; England, Bartlett, & 
Knuth, 1982; England, et al., 1985; Hixon & Hoit, 2005; Iwarsson, 2001; Iwarsson, et al., 1998; 
Kuna, McCarthy, et al., 1993). Of particular concern in the present context are the possible 
etiologic effects that respiratory abnormalities may have for pathogenesis in selected voice 
disorders. The issue is a non-trivial one. In addition to the estimated 25% of the US population 
with dyspnea (Hoit, et al., 2007), voice problems affect 3-9% of the general population at any 
given point in time (Verdolini & Ramig, 2001). Further, up to 40-70% of clinical voice caseloads 
Disorder Hypercapnia Hypocapnia 
Asthma X X 
COPD X X 
Anxiety disorder  X 
Panic disorder  X 
Somatic Illness X  
Neuromuscular disorders X  
Chest Wall disorders X  
MTD-1 ? ? 
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are reportedly comprised of individuals with Primary Muscle Tension Dysphonia (MTD-1) 
(Angsuwarangsee & Morrison, 2002; Roy, 2003), generally defined as a voice disturbance in the 
absence of known structural or neurologic abnormalities (Roy, 2003), but often with at least 
partial presumed etiology in abnormal respiration (Behrman, 2005; Hixon & Hoit, 2005; Hixon 
& Putnam, 1983; Iwarsson, 2001; Koufman & Blalock, 1988; Morrison, 1997; Morrison & 
Rammage, 1993). Respiratory complaints, such as phonatory dyspnea, are common among 
individuals with MTD-1 (Nguyen, et al., 2009). Published reports have pervasively described a 
general “dyscoordination” between respiration and phonation, and problems with breath 
“control,” in individuals with MTD-1 (Behrman, 2005; Hixon & Hoit, 2005; Hočevar-Boltežar, 
et al., 1998; Koufman & Blalock, 1988; Morrison, 1997; Morrison & Rammage, 1993). In 
addition to such general observations, the literature also specifically describes paradoxical 
breathing (Iwarsson, 2001), shallow breathing (Koufman & Blalock, 1988), and use of low lung 
volumes in MTD-1 (Iwarsson, et al., 1998). During phonation in some individuals, the larynx 
may act as more of a gross respiratory control valve than as a finely-tuned modulator needed to 
transform pulmonary airflows into systematic acoustic waves (Morrison & Rammage, 1993). 
Many of these observations are also made in people with lower airway disease.  
Of note, to date the primary etiologic factors that have been systematically investigated in 
MTD-1 are psychological. For example, individuals with MTD-1 are likely to have greater 
anxiety than healthy controls or individuals with other voice problems (Anbar, 2002; Dietrich, 
Verdolini Abbott, Gartner-Schmidt, & Rosen, 2008; Homnick & Pratt, 2000; House & Andrews, 
1987; Kinzl, et al., 1988; Leo & Konakanchi, 1999; Millar, et al., 1999; Powell et al., 2007; Roy, 
Bless, & Heisey, 2000; Roy, McGrory, et al., 1997; van Mersbergen, Patrick, & Glaze, 2008; 
Willinger, et al., 2005). Furthermore, abnormal laryngeal and perceptual voice quality findings 
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are common in individuals with respiratory disorders (Cohen, 2010; Dogan, et al., 2007; 
England, et al., 1985; Hackenberg, et al., 2010; Stanton, et al., 2009). Laryngeal resistance 
during breathing changes with varying levels of arterial CO2, conditions experienced by people 
with lower airway disorders (Brancatisano, et al., 1983; England, Bartlett, & Knuth, 1982; 
England, et al., 1985). Laryngeal resistance during phonation is known to be stable in normal 
speakers (Grillo & Verdolini, 2008; Leeper & Graves, 1984), however resistance measures are 
shown to be abnormal in individuals with voice problems (Gillespie, et al., 2012; Higgins, et al., 
1999; Hillman, et al., 1989b). The mechanism by which the apparently regulated stability of the 
voice motor system-- and within that system, laryngeal resistance during phonation -- is altered 
in individuals with voice problems remains unknown. The driving hypothesis for the present 
study is that respiratory issues involved in such voice problems represent a common pathway in 
people with voice problems, whether they originate in psychological disorders or in physical 
disease. 
 
5.1 HYPOTHESES 
The current study expands on well-established knowledge regarding the role of the larynx in 
homeostatic regulation of blood-gas concentrations (Bartlett, 1979; Brancatisano, et al., 1991; 
England, Bartlett, & Daubenspeck, 1982; England, Bartlett, & Knuth, 1982; Kuna, McCarthy, et 
al., 1993). Unfortunately, to date, studies on the respiratory versus phonatory functions of the 
larynx have demonstrated remarkably little cross-talk, which this series hopes to incorporate. The 
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theoretical hypothesis was that when challenged to produce voice under conditions of varying 
CO2 levels, the larynx would sacrifice phonatory resistance stability in favor of respiratory 
resistance mechanisms tending to return the system to physiologic homeostatic baseline. It was 
hypothesized that the respiratory perturbations would overcome the apparently inherent stability 
of phonatory laryngeal resistance and revert the larynx’s function to one primarily responsible 
for responding to respiratory needs. This study was the first to study the effects of respiratory 
condition on laryngeal physiology during phonation and to identify the larynx’s varying 
functions at the intersection of respiration and communication. Specifically, this study 
represented the second step in a programmatic line of research that will ultimately lead to future 
studies investigating causal relations between respiratory-induced adjustments in laryngeal 
resistance, phonatory adaptations in individuals with respiratory disorders such as COPD and 
asthma, psychological disorders such as anxiety and panic, and specific voice disorders such as 
MTD-1. Future studies will also investigate respiratory bio-markers useful for identifying 
individuals at risk for MTD-1 and other pathologies affecting voice, and will establish new 
approaches to their evaluation and treatment.  
Specific hypotheses were: phonatory laryngeal resistance will increase during hypocapnia 
(SA1a) and decrease during hypercapnia (SA1b), favoring a return towards respiratory 
homeostasis, and amount of phonatory laryngeal resistance will in turn attempt to return the 
respiratory system to homeostasis (SA2). Data to this effect would provide critical evidence on 
how respiratory and laryngeal functions may interact in phonation under conditions of 
respiratory abnormality. Data would also provide evidence on the stability of phonatory 
laryngeal resistance during substantial respiratory perturbations similar to those experienced by 
individuals with respiratory disorders.   
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6.0  METHODS 
6.1 PARTICIPANTS 
Healthy females, ages 18-45 years, were recruited from the Pittsburgh metropolitan region. 
Based on estimates from past research on phonatory laryngeal airway resistance (Grillo & 
Verdolini, 2008), using a repeated measures design with an alpha of .05, and an anticipated 
moderate effect size, a sample size of 20 participants would be necessary to achieve 80% 
statistical power for SA1, the primary aim of interest. However, because the experiment utilized 
counterbalancing across 3 conditions, the total number of participants required to complete the 
experiment had to be a multiple of 6. Therefore, we targeted a total of 24 participants to 
complete the experimental procedures. Females were the focus for this initial study, as women 
experience voice problems in general, and MTD-1 specifically, more commonly than males 
(Roy, 2003). 
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6.2 INCLUSION/EXCLUSION CRITERIA 
Inclusion/Exclusion criteria were: 
 By self-report: Female, non-smoker, age 18-45 years (to limit hormonal influences on 
voice); negative history of voice problems (voice disturbance lasting for greater than 2 weeks, or 
recurring greater than 3 times during the preceding year) or history of any prior voice treatment; 
negative history of respiratory disorders including asthma, COPD, emphysema, sleep apnea; 
negative history of psychological disorders including depression, anxiety, panic disorder; 
negative history of vocal training (defined as any private study in vocal performance); and 
negative history of use of any medication that might affect voice.  
 By clinical judgment (PI): English comprehension and hearing sufficient to provide fully 
informed consent and follow study instructions; speech production sufficient to produce the 
target phoneme /pa/. 
 By instrumental assessment: Not pregnant (by administration of a urine pregnancy test); 
normal vocal quality as judged by CAPE-V score independently judged by a rater not otherwise 
involved in the study (masters level speech-language pathologist specializing in voice); normal 
hearing as determined by hearing screening (30dB at 500, 1000, 1500, and 2000 Hz bilaterally); 
no self-perceived voice problem as determined by Voice Handicap Index-10 (VHI-10) score < 
11 (Arffa, Krishna, Gartner-Schmidt, & Rosen, 2012; Rosen, Lee, Osborne, Zullo, & Murry, 
2004), no indication of laryngopharyngeal reflux affecting voice as determined by a Reflux 
Severity Index (RSI) score <13 (Belafsky, Postma, & Koufman, 2002); normal larynx as judged 
independently by the PI and a fellowship trained laryngologist, based on rigid or flexible 
endoscopy; normal pulmonary function as determined by flow-volume loop spirometry 
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performed by the PI and confirmed by a senior pulmonary lab technician (Miller et al., 2005). 
Further details regarding instrumented assessment criteria are provided shortly. 
6.3 RECRUITMENT 
Potential participants were recruited with flyers distributed on the University of Pittsburgh’s 
Pittsburgh campus and on the internet (www.craigslist.org) (Figure 6.1).  
37 
 
 
Figure 6.1. Recruitment flyer. 
 
38 
 
6.4 EXPERIMENTAL DESIGN 
The primary focus of the study, addressed in SA1, involved a within-subjects repeated measures 
design. The independent variable was experimental respiratory condition (eupnea, hypocapnia, 
and hypercapnia). The dependent variable was laryngeal resistance (estimated Psub in cmH2O/ 
glottal airflow in L/sec) (SA1a, b). Secondary outcome measures of this aim included 
fundamental frequency (F0) and vocal intensity (dB SPL). A secondary focus, addressed in SA2 
but derived from the same within-subjects experimental run, involved a 3 x 2 within-subjects 
design. Independent variables were experimental condition (eupnea, hypocapnia and 
hypercapnia) and phonation (yes/no). The dependent variable was end-tidal CO2 (PetCO2).   
6.5  EQUIPMENT 
Screening Phase. Equipment used for the screening phase included flexible nasendoscope 
(Olympus Medical, Center Valley, PA), Koko spirometer (Grace Medical, Kennesaw, GA), 
Audiometer (Maico Diagnostics, Eden Prarie, MN), Pregnancy Test Strips (Wondfo, 
Willowbrook, IL), Matrix MR500 Metronome, and Computerized Speech Laboratory 
(KayPENTAX, Montvale, NJ, USA). 
Pre-experimental training. The Phonatory Aerodynamic System 6600 (PAS6600) (KayPENTAX, 
Montvale, NJ, USA) was used during pre-experimental training. 
Experiment. For the experiment proper, equipment included the PAS6600 (KayPENTAX, 
Montvale, NJ, USA), Matrix MR500 Metronome , Hans-Rudolph Model 2700 low-resistance 
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non-rebreathing valve used for each subject and sanitized between subjects per manufacturer’s 
instructions (Hans Rudolph, Inc., Shawnee, KS, USA), the Viasys Data Acquisition System 
(SensorMedics/Viasys Corp, Yorba Linda, CA, USA), ECG-gated pulse oximetry (Model 504-
USP, Criticare Systems Inc., Waukesha, WI, USA) and 5-lead ECG/BP monitor/recorder (Model 
Sirecust 732, Siemens Medical Systems, Inc. Danvers, MA, USA), room-air H cylinder, 7% CO2 
cylinder (Praxair Inc., Danbury, CT, USA), and balloon collection bags (Vacumetrics, Inc., 
Ventura, CA, USA). 
6.6 EQUIPMENT CALIBRATION 
For the PAS6600, the air-pressure tube and pneumotach were calibrated daily, per manufacturer 
instructions. Specifically, the system automatically calibrated the air-pressure tube upon the 
experimenter’s selection of Calibrate Air Pressure Zero Level from the system’s Options menu. 
To calibrate the pneumotach, a 1.0L syringe was coupled to the airflow head. The syringe 
plunger was depressed in one continuous motion for 2-4 seconds, emptying the syringe air into 
the pneumotach. The system then provided a calibration value. Proper calibration resulted in a 
value of 1.0L +/- 1-2%. Calibration of the Viasys Data Acquisition System was also required, 
and was completed before running each new participant. In a similar fashion to calibration for 
the PAS6600, a 3.0L syringe was coupled to the Viasys pneumotach and depressed. Proper 
calibration resulted in a value of 3.0L +/- 1-2%.  
The gas sensors were also calibrated and the gas-sensor tubing was replaced to avoid 
contamination due to condensation prior to the start of each new participant in the experiment.  
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The gases were calibrated by two-point certified calibration gas mixtures prior to each study. 
Finally, the microphone was calibrated daily. Given the connection of valves and tubing to the 
terminal end of the PAS6600 pneumotach, the microphone had to be repositioned from the 
terminal end of the pneumotach, to the left side of the facemask.  The change of microphone 
position is shown in Figure 6.2. Because the microphone is calibrated internally by the 
manufacturer (KayPENTAX) to represent 15cm from the speaker’s mouth, it had to be re-
calibrated to account for any recorded dB SPL changes in its new position.  Per the 
manufacturer’s direction (personal communication, Steve Crump, 6/12/2012) a 200Hz pure tone 
was generated via standard computer speakers against the facemask.  The dB SPL value was first 
recorded with the microphone in the original position.  Then, without changing the audio input, 
the microphone was moved to the experimental position and the dB SPL value was again 
recorded.  The difference between the dB SPL of the original and experimental microphone 
positions was recorded and used to adjust the dB SPL values of the experimental task in later 
analysis.  
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Figure 6.2. Re-positioned microphone (to the right of the yellow star). Facemask is visible in 
lower right corner. 
Face mask 
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7.0  EXPERIMENTAL PROCEDURES 
7.1 SCREENING 
Each participant provided informed consent before proceeding with any of the instrumental 
screening or experimental procedures. After consent had been obtained, first, satisfaction of self-
report and clinician rated inclusion/exclusion were confirmed (see 6.2). Next, the participant 
completed the Voice Handicap Index-10 (VHI-10) and Reflux Symptom Index (RSI) via an 
online secure form (see Appendix). Scores on the VHI-10 of less than 11, and RSI less than 13 
were considered normal (Arffa, et al., 2012; Belafsky, et al., 2002; Rosen, et al., 2004). If 
eligible based on these criteria, the participant was invited to attend an in-clinic screening. At the 
in-clinic screening, participants first completed a urine-pregnancy test to confirm non-pregnant 
status. Then, the participant’s height and weight were recorded using a standard scale and 
stadiometer. Next, the participant’s voice was recorded following the standard protocol for the 
Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) and judged for normalcy by a 
master’s level speech-language pathologist specializing in voice, with no knowledge of the 
experimental hypotheses.  Then, a hearing screening was performed to confirm normal hearing 
bilaterally at 30dB at 500, 1000, 1500, 2000 Hz. Next, laryngeal examination was performed by 
a fellowship trained laryngologist, using flexible endoscopy. The participant was positioned 
upright, and both nasal passages were sprayed with a local anesthetic (e.g. Cetacaine®). When 
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sufficient numbing had been achieved based on participant report and clinician evaluation, the 
flexible nasendoscope was passed through the most patent naris into the laryngopharynx, until 
the larynx was fully visualized. The initial portion of the examination involved halogen lighting 
of the larynx at rest during breathing. The larynx was then visualized under both halogen and 
stroboscopic illumination during sustained /i/ at comfortable (spontaneous/modal) and high 
pitches (about one octave higher than spontaneous comfortable pitch) and quiet and comfortable 
intensity, empirically determined, at both pitches. The laryngologist made a subjective 
determination about laryngeal normalcy. A normal laryngeal appearance was defined as no 
visible lesions, normal arytenoid dynamics on ab/adduction, normal vocal fold shortening and 
lengthening with pitch changes, and expected phonatory glottic closure. Impression of normal 
larynx was confirmed by the PI. Normal pulmonary functioning was determined with spirometric 
testing, per American Thoracic Society (ATS) standards (Miller, et al., 2005). This testing was 
conducted by the PI using the KoKo Spirometer, following ATS guidelines. Specifically, 
participants performed a sequence of four tidal breaths into a mouthpiece, followed by a deep 
inspiration and forceful, prolonged expiration. This procedure was repeated 3-8 times. 
Participants were required to achieve 3 normal results. Results judged as “normal” were free 
from artifacts, including observation or evidence of cough, glottic closure, early termination, or 
perceived sub-maximal effort; results confirm expiration for at least 6 seconds, and forced vital 
capacity (FVC) and forced expiratory volume in one second (FEV-1) were greater than 80% of 
predicted normal value (Miller, et al., 2005). Participants who failed to achieve three normal 
results after eight attempts were dismissed and excluded from further study participation.  
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7.2 PRE-EXPERIMENTAL SET-UP AND TRAINING FOR RLAW PROCEDURES 
After eligibility criteria were satisfied, the participant was trained in data collection procedures 
that were to be used for the subsequent experiment, specifically for the collection of phonatory 
laryngeal airway resistance measures (Rlaw). Although Rlaw, calculated as estimated Psub (cmH20) 
/average phonatory airflow (L/sec), has been shown to not significantly change when measured 
over two days at multiple time points (Leeper & Graves, 1984), some data do indicate that one 
component aspect of Rlaw (Psub) may be susceptible to practice effects. Specifically, according to 
one report, a threshold permutation of Psub, phonation threshold pressure, varies across 
performance days, whereby the best performance is typically not shown until Day 2 of 
performance (Dastolfo, 2011). Therefore, to err on the side of caution, and to avoid practice 
effects during the experiment proper, participants were trained in Rlaw data collection procedures 
the day prior to the experiment, at the time of screening. The Rlaw task utilized the PAS6600. 
This system’s hardware consists of a pneumotach coupled to a facemask with an integral intra-
oral pressure tube, and external microphone. The speaker phonates into the facemask with the 
intra-oral pressure tube placed in the mouth, on top of the tongue. Expired air flows to the 
pneumotach, which consists of a stainless steel mesh screen with pressure transducers on either 
side. The system calculates the pressure difference on either side of the screen to determine 
airflow rate. Psub is estimated by calculating intra-oral pressure in the pressure tube in the mouth 
during the production of a voiceless stop (e.g. /p/) in a consonant-vowel sequence. Sound is 
captured by a microphone re-located to the left of the facemask (see Figure 6.2) approximately 
15 cm from the participant’s mouth. 
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 For the Rlaw task itself, the PI trained the participant to produce a string of five 
consonant-vowel (CV) syllables (/pa pa pa pa pa/) on one breath, at a rate of 1.5 syllables/second 
(or 90 beats per minute, guided via metronome). Care was taken by the PI to assure the 
participant fit the facemask snugly over nose and mouth during task production, and that the 
pressure tube was sitting lightly on top of the tongue. For the experiment only, the face mask was 
secured with an elastic strap around the participant’s head to avoid any change in mask position. 
This set-up is shown in Figure 7.1. The morphology of pressure peaks and airflow plateaus was 
inspected visually for each syllable. Morphology was considered acceptable if pressure peaks 
were not pointy or jagged, and flow minima corresponded with pressure maxima, based on visual 
inspection (Helou & Solomon, 2011). Training ceased when the participant produced the CV 
string with peaks 2-4 showing acceptable morphology, as verified by the PI based on output from 
the PAS6600 (Helou & Solomon, 2011; Smitheran & Hixon, 1981). The participant was then 
sent home and asked to return the following day for the experiment proper. 
 
7.3 GENERAL SET-UP FOR EXPERIMENTAL DAY 
Participants were seated comfortably in a standard desk chair. Heart rate and oxygen (O2) 
saturation were measured using a 5-lead ECG and transcutaneous O2 saturation monitor, 
respectively. The participant’s nose and mouth were fit snugly into a standard anesthesia 
facemask, connected to the PAS6600. The facemask was secured around the participant’s head 
with an elastic band. The mask was visually inspected by the PI to ensure a leak-free seal on the 
46 
 
face. Figure 7.1shows the positioning of the facemask on one participant. Written permission to 
use the participant’s photo was received.  
 
Figure 7.1. Facemask positioned with elastic around participant's head (figure used with 
participant’s permission). 
 
The PAS6600 system was connected to a Hans-Rudolph valve. The Hans-Rudolph valve 
is a one-way valve that allowed the participant to inspire a given concentration and volume of 
air, and expire into the atmosphere to prevent re-breathing of expired air. At the point of 
connection between the PAS6600 and Hans-Rudolph valve were integral ports for airflow and 
gas concentration sensors. These connections are shown in Figure 7.2. These sensor lines 
connected into the Viasys Data Acquisition System. This system provided real-time breath-by-
breath analyses of respiratory data.  
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Figure 7.2. Connection of PAS6600 to Hans Rudolph valve with airflow and gas sensor lines. 
 
For the purposes of the current study, arterial CO2 was estimated by measuring the partial 
pressure of CO2 in expired air- the end-tidal partial pressure of CO2 (PetCO2) (Levitzky, 1995). 
Plastic tubing connected the Hans-Rudolph valve to a rubber balloon collection bag, which was 
connected to one of two H-cylinders. The H-cylinders were identical in size and shape and 
contained either room air (21% O2, .05% CO2, 78% Nitrogen) or enhanced CO2 (7% CO2, 21% 
O2, balanced Nitrogen). A rotameter connected to the cylinders allowed the examiner (Mr. 
Slivka, senior pulmonary technician and project consultant) to select the appropriate cylinder and 
control the flow rate of gases from that cylinder to the participant. The examiner, blinded to 
experimental hypotheses, controlled the rotameter to meter either the room air or CO2 enriched 
air to the participant and to change the volume of airflow being inspired. Figure 7.3 shows the 
experimental set-up on one participant. All three conditions utilized air from one of the two 
cylinders. The order of eupneic, hypo- and hypercapnic conditions was counterbalanced across 
participants to control for order effects. Then, each counterbalanced set of conditions was 
randomly assigned to each participant. Each experimental condition lasted approximately five 
Flow sensor 
 
Gas sensor 
Hans-Rudolph valve 
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minutes (Table 7.1). Baseline data collection, described next, lasted five minutes. There were 
also three 15-minute breaks after each condition (Gorman et al., 1994; Papp et al., 1997), for a 
total of approximately 65 minutes experimental time per participant. Subjects were compensated 
$50 for completing the entire protocol, or $10 for any partial completion. 
 
 
Figure 7.3. Participant in experimental chair with gas cylinders in background (figure used with 
participant’s permission). 
 
 
 
 
 
Experimental H-cylinders 
 
PAS6600 computer 
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Table 7.1.  Template for Experimental Procedures. The Order of Breathing Conditions 
was Counterbalanced and Randomized Across Participants 
Condition Activity Duration 
Baseline Participant performs normal, tidal breathing, no phonation 5 minutes 
Eupnea Participant breathes room air 5 minutes 
Rlaw task 
Rest Rest 15 
minutes 
Hypocapnia Participant breathes room air metered from an H-cylinder at 2x the 
participant’s resting respiratory rate 
5 minutes 
Rlaw task 
Rest Rest 15 
minutes 
Hypercapnia Participant breathes CO2 enriched air metered from an H-cylinder  5 minutes 
Rlaw task 
Rest Rest 15 
minutes 
 
7.4 EXPERIMENTAL PROCEDURES 
7.4.1 Baseline 
For the experimental procedures proper, first a respiratory baseline was obtained for each 
participant. For baseline data collection, the participant sat with the facemask in place as 
previously described and breathed room air. Baseline tidal volume (Vt), minute volume (VE), 
inspiratory time (Ti), expiratory time (Te), respiratory rate (RR), PetCO2, heart rate (HR), and 
transcutaneous O2 saturation (O2) data were collected using the Viasys pulmonary data 
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acquisition system, 5-lead ECG, and ECG-gated pulse oximetry, respectively. Baseline data were 
collected and analyzed on a breath-by-breath basis for 5 minutes of tidal breathing. Sixty-second 
averages of the third, fourth and fifth minute of baseline breath-by-breath values of PetCO2, 
resting respiratory rate, and resting tidal volume were calculated by the computer, and then those 
three values were averaged to provide one baseline value for each variable of interest. Baseline 
PetCO2 values were used to determine the target hypocapnic range for each participant, described 
shortly. Baseline minute volume was used to determine the starting minute volume rate required 
to induce hyperventilation for the hypocapnic condition described next. 
 
7.4.2 Intervention 
Following collection of baseline data, each participant underwent the following interventions, 
counterbalanced across subjects (See Table 7.1). First, the voice task (three sets of five 
productions of /pa/) was reviewed and the participant practiced the task to conform to criteria 
(pressure peaks not pointy or jagged, and flow minima corresponded with pressure maxima, 
based on visual inspection). For the eupneic condition, the participant breathed room air through 
the cylinder, metered in at the participant’s baseline minute volume, and produced the Rlaw task 
five times, with a breath between each production. As for all experimental conditions, a 15-
minute break followed, during which time the participant removed the face mask and breathed 
normally. Fifteen minutes was selected as the rest time, as the literature indicates that 15 minutes 
of normal breathing is sufficient to allow respiratory variables to return to baseline following 
experimental challenge (Gorman, et al., 1994; Papp, et al., 1997). During the final five minutes 
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of rest, the participant again breathed through the mask, open to the atmosphere, to capture the 
same respiratory data as previously (PetCO2, VE, RR, HR, and O2) and confirm return to 
baseline.  
For the hypocapnic condition, the examiner metered room air at a rate triple the 
participant’s resting respiratory minute volume as determined during baseline procedures, via the 
cylinder containing room air, to the participant. The participant was instructed to visually 
monitor the rubber balloon collection bag positioned between the facemask and the cylinder, as it 
filled with air, and to breathe as quickly as possible to keep the bag from fully inflating or 
completely deflating. The minute volume was increased in 5L increments until the participant’s 
PetCO2 reached 50% +/- 2 mmHg of the baseline value. This procedure resulted in spontaneous 
hyperventilation for each participant. This method of achieving hypocapnia has been 
demonstrated in the pulmonary literature, and was also confirmed with our pre-experimental 
feasibility testing (Antony, Brown, & Barlow, 1997; Rapee, Brown, Antony, & Barlow, 1992; 
Zvolensky & Eifert, 2001). The PI monitored the breath by breath analysis to determine when 
the participant had reached the hypocapnic state. Once the participant’s PetCO2 was 50% +/- 2 
mmHg of baseline for 30 seconds (steady state), the participant was instructed to perform the 
Rlaw task five times, as previously trained. The gas was turned off during each voiced production 
to reduce noise interference with the voiced data collection. Again, a 15-minute break followed. 
For the hypercapnic condition, the 7% CO2 gas was delivered via a 60 liter Douglas bag. 
The participant first breathed room air and the CO2 gas mixture was silently switched to 
the inspiratory limb of the breathing circuit (Antony, et al., 1997; Gorman, et al., 1994; Hoit, et 
al., 2007; Papp, et al., 1997). The PI monitored the breath-by-breath analyses to determine when 
the participant had reached the hypercapnic state. Once the participant’s PetCO2 reached 50 
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mmHg (+/- 2 mmHg) for 30 seconds (steady state), the participant was instructed to perform the 
Rlaw task five times. The hypercapnic gas was delivered continuously during the trial. Another-15 
minute break of breathing room air followed with the final five minutes of rest recorded to 
ensure return to baseline of all variables.  
During the steady state portions of the eupneic, hypocapnic, and hypercapnic trials, i.e., 
30 seconds prior to the onset of phonation, PetCO2, VE, RR, HR, Ti, Te, and O2 were values 
recorded. These variables were also recorded during the Rlaw task performance in each of the 
conditions. The difference between PetCO2 in each condition (without phonation during steady 
state, and with phonation during Rlaw) was later analyzed for statistically significant differences.  
 
7.4.2.1 Blinding 
All experimental conditions required the participant to breathe gas from a cylinder through a 
facemask. The participants were not informed which gas concentration they were breathing 
during the experiment.  However, each condition produced a change in breathing pattern, so 
participants were aware the conditions were different. All collected data were saved under an 
alpha-numeric code linked to the condition name (e.g. “A” was always the first condition, which, 
based on counter-balancing, might have involved hypocapnia, hypercapnia, or eupnea). All Rlaw 
analyses were conducted by a master’s level speech-language pathologist specializing in voice 
with substantial experience analyzing aerodynamic data, and who was blinded to subjects’ 
condition. 
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7.5 DATA REDUCTION 
All data reduction was completed by the PI and another member of the PI’s doctoral lab, a 
master’s level speech-language pathologist specializing in voice with substantial experience 
analyzing aerodynamic data, who was blinded to experimental condition. Five repetitions of the 
/pa/ utterance were completed for each condition. Following each experimental condition, the 
entire aerodynamic signal was saved. Then, the Rlaw signal was magnified and the middle three 
(of five) tokens were trimmed and saved for analysis. For calculation of Rlaw, first the middle 
three pressure peaks generated during the /p/ of each five-syllable /pa/ string were manually 
selected and examined for acceptable morphology (Smitheran & Hixon, 1981). The 
corresponding flow signal during the voiced /a/ was also manually selected and inspected. 
Specifically, the signals were inspected to ensure pressure returned to baseline during the vowel, 
and airflow returned to baseline during the consonant (Smitheran & Hixon, 1981). The middle 
three tokens were selected as default for analysis unless the morphology of the pressure peaks 
and airflow plateaus were deemed unacceptable, in which case the best three of five tokens (of 
any set) were saved and analyzed. Of note, a build-up of pressure from an increase in dead space 
due to the lengthening of the tube beyond the terminal end of the PAS6600 pneumotach 
prevented the pressure signal from returning to zero between syllables. Therefore, the pressure 
value was calculated by subtracting the baseline pressure (above zero) from the peak pressure. 
The physical experimental set-up disallowed the PI from monitoring sample requirements during 
collection. Therefore, though three syllable strings were required for analysis, five sets of data 
were collected in order to discard any syllable strings not satisfying the criteria. An example of 
one Rlaw set with baseline pressure above zero is shown in Figure 7.4. Once deemed acceptable, 
54 
 
the average pressure and airflow signals from the respective syllables were selected and the 
values manually recorded. The same procedure was repeated for the middle three trials (of five) 
for each condition (eupnea, hypocapnia, hypercapnia), and data used in statistical analyses. The 
PetCO2 values recorded via breath-by-breath analysis were also recorded during the periods of 
interest, that is, during the 30-sec non-phonated steady state portions of the eupneic, hypocapnic, 
and hypercapnic trials, as well as during the Rlaw task for each condition. The breath-by-breath 
values were averaged over the time of interest, and the averaged values used for analyses. Ten 
percent of data were reanalyzed by the PI for evaluation of reliability. 
 
Figure 7.4. Example of PAS6600 data for 3 sets of /pa/ for one participant. 
7.6 STATISTICAL ANALYSES 
All statistical analyses were conducted using SPSS19.0. For primary statistical analyses, the 
independent variable was experimental condition (eupnea, hypocapnia, and hypercapnia) and the 
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dependent variable was laryngeal resistance (estimated Psub in cmH2O/ glottal airflow in L/sec). 
A within-subject Analysis of Variance (ANOVA) was run on these data. For secondary analyses, 
independent variables were experimental condition (eupnea, hypocapnia and hypercapnia) and 
phonation (yes/no), and the dependent variable was PetCO2. A 2-way within-subjects ANOVA 
(condition x phonation) was performed on these data. The alpha level was set to .05 for each test, 
without protection for alpha inflation due to the preliminary nature of the study. Interaction 
effects were tested first, if an interaction was found, main effects were then investigated. If a 
significant main effect of condition was found, post-hoc comparisons using Bonferroni 
adjustment were performed. The components of Rlaw – estimated subglottal pressure (Psub) and 
laryngeal airflow -- were also analyzed with a one-way within-subjects ANOVA, to determine 
each part’s contribution to the overall result.  Due to the possible influence of subjective human 
error and variability in selection of tokens for Rlaw analysis, Rlaw reliability was assessed by the 
Interclass Correlation Coefficient. 
7.7 INNOVATION 
This study represented the first to analyze laryngeal airway resistance during phonation in 
conditions of hyper- and hypocapnia. These respiratory conditions are experienced daily by 
individuals with respiratory, psychological, and other disorders. Speech characteristics in 
hypercapnia (Hoit, et al., 2007; Russell, Cerny, & Stathopoulos, 1998), and laryngeal resistance 
during breathing but not during phonation have been studied by other authors (Bartlett, 1979; 
Brancatisano, et al., 1991; England & Bartlett, 1982; England, Bartlett, & Knuth, 1982; England, 
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et al., 1985; Kuna, McCarthy, et al., 1993). The influence of phonation on the larynx’s role as a 
part of the respiratory system has not previously been investigated.  
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8.0  RESULTS 
8.1 PARTICIPANTS 
Fifty-seven potential participants were screened. Figure 8.1 provides information on all screened 
participants. Twenty-four satisfied all of the inclusion/exclusion criteria and participated in the 
study. All individuals who initiated the study completed it. Rlaw Data from two participants were 
excluded from final Rlaw analyses due to task violations (explained shortly). Table 8.1 and Table 
8.2 provide demographic information including age, ethnic and racial category, participant 
perceived voice handicap (VHI-10), participant perceived reflux symptoms (RSI), and clinician-
rated perceptual overall voice quality (CAPE-V) for each subject who participated. 
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Figure 8.1 Participant flow chart 
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Table 8.1. Number of Participants in Each Racial and Ethnic Category; Range and Mean of 
Participant Ages 
Hispanic Non-
Hispanic 
White/Caucasian Black/African 
American 
Asian Age 
range 
Age 
mean 
2 22 15 3 6 19-45 24.58 
 
 
 
Table 8.2. Range and Means for CAPE-V, VHI-10 and RSI Scores for Participants 
CAPE-V (max score: 100, 
higher score = worse) 
VHI-10 (max score: 40, 
higher score = worse); 
Normative M = 7, SD = 2 
RSI (max score: 50, 
higher score = 
worse); Normative M 
= 11, SD = 2  
range mean SD range mean SD range mean SD 
0-3 0.75 0.79 0-6 1.08 1.61 0-10 2.13 2.63 
 
8.2 PRIMARY OUTCOMES 
8.2.1 Phonatory Laryngeal Resistance (Rlaw)  
The first hypothesis was that the larynx would sacrifice its phonatory resistance mechanisms in 
favor of respiratory resistance mechanisms, tending to return the system to physiologic 
homeostatic baseline under conditions of ventilatory perturbation. For investigation of this aim, 
phonatory laryngeal resistance (Rlaw) was measured during conditions of induced hypocapnia, 
hypercapnia, and eupnea. Rlaw data for 22/24 participants were available for final analyses. Two 
participants’ data were excluded due to data violations in at least one condition (e.g., airflow not 
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returning to zero baseline during the voiceless pressure build). For analysis, these data were 
considered missing at random. Because the study used a repeated measures design, when one 
condition contained no analyzable data, the other conditions were therefore not useable, and all 
data for that participant were excluded from the final analysis.  
Descriptively, participants’ Rlaw responses to the breathing conditions demonstrated 
mutually opposing contrasting results.  Rlaw was greater in the hypocapnic condition than the 
hypercapnic condition in 12/22 (55%) participants. The opposite result, showing greater Rlaw in 
hyper- as opposed to hypocapnia – occurred in 10/22 (45%) participants (Figure 8.2).  
 
Figure 8.2. Number of participants in each breathing condition with greater Rlaw. 
  
When eupnea Rlaw values were added to the descriptive analysis, the values represented 
all six possible combinations of Rlaw directions (Table 8.3). The group with the most participants 
(n = 6) demonstrated the lowest Rlaw values in the eupnea condition, followed by hypercapnia, 
then hypocapnia. Results for a second group two (n = 5) were consistent with the experimental 
hypothesis, that Rlaw values would be lowest in the hypercapnic condition, intermediate during 
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eupnea, and greatest in the hypocapnia condition.  Rlaw values for a third group (n = 5) were 
lowest in eupnea, followed by hypocapnia, then hypercapnia. Group four’s Rlaw values (n = 3) 
were lowest in hypocapnia, followed by hypercapnia, then eupnea. Group five (n = 2) 
demonstrated the lowest Rlaw values for hypocapnia, followed by eupnea, then hypercapnia. The 
final group (n = 1) had the lowest Rlaw values for hypercapnia, then hypocapnia, followed by 
eupnea. 
Table 8.3. Combinations of Rlaw Directions 
# of participants Direction of Rlaw values 
(lowest – middle – greatest) 
6 Eupnea Hypercapnia Hypocapnia 
5 Hypercapnia Eupnea Hypocapnia 
5 Eupnea Hypocapnia Hypercapnia 
3 Hypocapnia Hypercapnia Eupnea 
2 Hypocapnia Eupnea Hypercapnia 
1 Hypercapnia Hypocapnia Eupnea 
 
A within-subjects Analysis of Variance was performed on phonatory laryngeal resistance 
(Rlaw) data as a function of breathing condition (eupnea, hypocapnia, hypercapnia). The 
assumption of sphericity was met (Mauchly’s W = .964, X2(2) = .723, p = .697). The assumption 
of normality was not met (Table 8.4). Therefore the data were transformed using natural 
logarithmic transformation. The transformed data met the assumption of normality (Table 8.5). 
However, the results of the analysis of variance were not affected by the transformation (F[2, 42] 
= 1.130, p = .333, partial η2 = .051). Therefore, results from analyses of the original un-
transformed data are reported here.  
Table 8.4. Test of Normality of the Untransformed Phonatory Laryngeal Resistance Values for 
Each Breathing Condition. 
Condition   Shapiro-Wilk W  df  p 
Eupnea             .818    22  .001 
Hypocapnia   .839    22  .002 
Hypercapnia   .707    22  .000 
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Table 8.5. Test of Normality of Phonatory Laryngeal Resistance Values after Natural 
Logarithmic Transformation for Each Breathing Condition 
 
Condition   Shapiro-Wilk W  df  p 
Log Eupnea    .958   22  .441 
Log Hypocapnia   .951   22  .323 
Log Hypercapnia   .938   22  .179 
 
The main effect of breathing condition was not significant for Rlaw, (F[2, 42] = .274, p = 
.762, partial η2 = .013). Means, standard deviations, and ranges for Rlaw in each breathing 
condition are displayed in Table 8.6. Inter-rater reliability of Rlaw data showed excellent 
correlation between raters (r = .988). 
 
Table 8.6. Means, Standard Deviations, and Ranges of Rlaw Values (cmH2O/L/sec) for Each 
Breathing Condition 
Condition  Mean  SD  Range 
Eupnea  50.27  28.43  12.17-139.20 
Hypocapnia  54.77  25.66  24.87-125.42 
Hypercapnia  52.31  30.67  17.76-168.29 
 
 
As previously noted, 6 combinations of Rlaw changes were observed across experimental 
conditions, indicating a substantial amount of variability in the data, and standard deviations 
were large.  Inspection of individual Rlaw data (Figure 8.3) in each condition speaks to this 
variability. Two participants had at least one Rlaw value that fell 4 standard deviations outside the 
mean for that condition, two participants had values 3 standard deviations from the mean, and 
four had values 2 standard deviations from the mean across all conditions. The remaining 14 
participants’ values were within 1 standard deviation of the mean. Interestingly, the mean Rlaw 
63 
 
values observed in these data for each breathing condition were well within 1 standard deviation 
of Rlaw values for normal speakers (Zraick, Smith-Olinde, & Shotts, 2012).  However, the failure 
to confirm the experimental hypothesis (lowest Rlaw values in hypercapnia and greatest values in 
hypocapnia) was not due to variability in the data: mean values were not positioned in the 
anticipated order, even descriptively. 
 
 
Figure 8.3. Rlaw values (cmH2O/L/sec) for each participant in each condition. Note: Eupnea 
Rlaw = Rlaw in the eupneic condition; Hypo Rlaw = Rlaw in the hypocapnic condition; Hyper 
Rlaw = Rlaw in the hypercapnic condition. 
 
 Figure 8.4 displays the relatively stable mean value of Rlaw throughout the range of 
PetCO2 values (with a slight decrease in Rlaw as PetCO2 values increased).  
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Figure 8.4. PetCO2 (mmHg) as a function of Rlaw (cmH2O/L/sec). 
8.2.2 Component Parts of Laryngeal Resistance 
In order to further explore the results for Rlaw, the component parts of the Rlaw ratio - mean 
translaryngeal airflow (airflow) and mean estimated sub-glottal pressure (Psub) -- were analyzed 
for differences across the breathing conditions.  
8.2.2.1 Translaryngeal airflow 
Nine total combinations of airflow directional patterns were observed. In 13/22 
participants, airflow was greatest in the hypocapnic condition. For those participants, eupnea was 
associated with the lowest flow in 3/13, hypercapnia was associated with the lowest flow in 7/13, 
and eupnea and hypercapnia produced identical flows for the remaining 3/13 participants. In 5/22 
subjects, hypercapnia produced the greatest flow. For those individuals, hypocapnia and eupnea 
produced identical flow values for two participants; flow in eupnea was less than hypocapnia in 
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two subjects; and hypocapnia was less than eupnea in one subject. Finally, for 2/22 participants, 
flow was greatest in the eupneic condition, and identical flows were observed in the hyper- and 
hypocapnic conditions.  
A within-subjects Analysis of Variance was performed on translaryngeal airflow as a 
function of breathing condition (eupnea, hypocapnia, hypercapnia). The assumption of sphericity 
was met (Mauchly’s W = .887, X2(2) = 2.41, p = .300). The assumption of normality was also 
met (Table 8.7).  Means, standard deviations, and ranges of airflow values for each breathing 
condition are shown in Table 8.8.  
Table 8.7. Test of Normality of Airflow Data 
Condition   Shapiro-Wilk W df  p 
Airflow   .973   69  .139 
 
Table 8.8. Mean, Standard Deviation, and Range of Airflow Values for Each Breathing 
Condition (L/sec) 
Condition   Mean  SD  Range 
Eupnea            .182  .076  .05-.39 
Hypocapnia   .213  .067  .11-.35 
Hypercapnia   .176  .058  .07-.26 
 
The main effect of breathing condition on airflow values was significant: F(2, 42) = 
5.225, p = .009, partial η2 = .199. Pairwise comparisons revealed airflow values were 
significantly higher in the hypocapnic condition than in the hypercapnic condition (p = .021). 
None of the other comparisons achieved significance. Figure 8.5 displays the airflow 
measurements for each subject in each experimental condition.  
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Figure 8.5. Airflow measurements (L/sec) for each participant in each experimental condition.  
Note: eupnea flow = flow in the eupneic condition; hypo flow = flow in the hypocapnic 
condition; hyper flow = flow in the hypercapnic condition. 
8.2.2.2 Minute ventilation 
In order to further explore the noted changes across conditions, changes in minute 
ventilation (L/min) in each breathing condition were also assessed. Minute ventilation is the 
product of tidal volume and respiratory rate. On average, participants increased minute 
ventilation by 43 L/min in the hypocapnic over the eupneic condition. Similarly, the hypercapnic 
condition caused an increase in minute ventilation as a response to elevating levels of CO2. On 
average, participants increased their minute ventilation by 12 L/min in the hypercapnic over the 
eupneic condition (Table 8.10).  
A within-subjects Analysis of Variance was performed on minute ventilation as a 
function of breathing condition (eupnea, hypocapnia, hypercapnia). The assumption of sphericity 
was met (Mauchly’s W = .841, X2(2) = 3.819, p = .148). The assumption of normality was met 
for the hyper- and hypocapnic conditions, but not for the eupneic condition (Table 8.9).  
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Table 8.9. Test of Normality for Minute Ventilation in Each Breathing Condition 
 Shapiro-Wilk 
W 
df Sig. 
Eupnea .486 24 .000* 
Hypocapnia .950 24 .275 
Hypercapnia .966 24 .578 
Note: * indicates significance at the .05 level. 
 
A significant difference in minute ventilation across breathing conditions was found: F(2, 
46) = 133.34, p < .001, partial η2 = .853. Pairwise comparisons showed minute ventilation values 
were significantly higher in the hypocapnic condition than in the hypercapnic condition, which 
were both significantly greater than in the eupneic condition (p < .001 for all comparisons) 
(Table 8.10). 
Due to the violation of the normality assumption for the eupnea condition, all three 
conditions were subjected to non-parametric testing with the Friedman Test for significance, as 
well as the parametric testing with ANOVA. The Friedman Test also detected a significant 
difference in VE among breathing conditions: χ2(2) = 40.583, p < .001. 
Post-hoc analysis with Wilcoxon Signed-Rank Tests was conducted with a Bonferroni 
adjustment, resulting in a significance level set at p < 0.017 for each test. There was a significant 
difference between VE for eupnea and hypocapnia (Z = -4.257, p < .001), between hypocapnia 
and hypercapnia (Z = -4.286, p < .001), and between hypercapnia and eupnea (Z = -3.714, p < 
.001).  VE was greatest in the hypocapnic condition, followed by hypercapnic, and finally 
eupneic.  
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Table 8.10. Minute Ventilation in Each Condition 
Condition M  Minute Volume (VE) 
(L/min) 
SD 
Eupnea 12.26 9.93 
Hypercapnia 23.92 10.77 
Hypocapnia 55.88 12.93 
 
8.2.2.3 Estimated sub-glottic pressure 
Unlike the variability observed in the airflow data, only two directional combinations of 
estimated sub-glottic pressure (Psub) data were found in the data set. For all participants, 
hypocapnia produced greater Psub than hypercapnia or eupnea. For 16/22 participants, the lowest 
Psub was observed during eupnea, followed by hypercapnia.  For 6/22 participants, hypercapnia 
produced the lowest Psub, then eupnea.  
A within-subjects analysis of variance was performed on estimated sub-glottic pressure 
(Psub) as a function of breathing condition (eupnea, hypocapnia, hypercapnia). The assumption of 
sphericity was not met (Mauchly’s W = .293, X2(2) = 24.53, p < .001), therefore Huynh-Feldt 
values are reported for tests of significance. The assumption of normality was met (Table 8.11).  
Means, standard deviations, and ranges of Psub values for each breathing condition are shown in 
Table 8.12.  
Table 8.11. Test of Normality of Psub Data by Experimental Condition 
Condition  Shapiro-Wilk W  df  p 
Eupnea             .958   22  .455 
Hypocapnia   .942   22  .221 
Hypercapnia   .969   22  .679 
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Table 8.12. Mean, Standard Deviation, and Range of Psub Values (cmH2O) for Each Breathing 
Condition 
Condition   Mean  SD  Range 
Eupnea              7.65  2.01  2.80-10.97 
Hypocapnia   10.62  3.00  5.72-15.25 
Hypercapnia     7.97  1.86  4.44-11.78 
*Note: all values in cmH2O 
 
A significant difference in Psub values across breathing conditions was found: F(1.19, 
25.18) = 37.130, p < .001, partial η2 = .639. Pairwise comparisons revealed significantly greater 
Psub values in the hypocapnic condition (M = 10.62 cmH2O, SE = .641) than the eupneic (M = 
7.65 cmH2O, SE = .429) and the hypercapnic (M = 7.97, SE = .397) conditions. None of the other 
comparisons achieved significance. The differences in Psub among the breathing conditions are 
graphed in Figure 8.6. 
 
 
Figure 8.6. Psub (cmH2O) values for each participant. 
 
Airflow and corresponding Psub values are displayed for each participant in each 
breathing condition in Figure 8.7,Figure 8.8Figure 8.9.  
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Figure 8.7 Airflow (L/sec) and Psub (cmH2O) for each participant in eupneic condition. 
 
 
Figure 8.8 Airflow (L/sec) and Psub (cmH2O) for each participant in hypocapnic condition. 
 
 
Figure 8.9 Airflow (L/sec) and Psub (cmH2O) for each participant in hypercapnic condition. 
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8.2.3 End-tidal Carbon Dioxide (PetCO2). 
End-tidal carbon dioxide (PetCO2) data for all 24 participants were acceptable for analysis. For all 
participants, PetCO2 values were lowest for hypocapnia, intermediate for eupnea, and greatest for 
hypercapnia.   
A 2x3 within-subjects Analysis of Variance was performed on PetCO2 values as a 
function of phonation (no phonation during steady-state and phonation during voice task) and 
breathing condition (eupnea, hypocapnia, hypercapnia). The assumption of sphericity was met 
for all effects independently (phonation: Mauchly’s W = 1.00; breathing condition: Mauchly’s W 
= .827, X2(2) = 4.174, p = .124; phonation by breathing condition: Mauchly’s W = .981, X2(2) = 
.420, p = .811). However, the assumption of normality was not met for pooled Pet-CO2 values 
(Table 8.13). The data were therefore transformed using a natural logarithmic transformation. 
The assumption of normality of the transformed data was still not met (Table 8.14). 
 
Table 8.13. Normality Test for PetCO2 Variable 
Variable  Shapiro-Wilk W  df  p 
PetCO2    .915   144  .000 
 
Table 8.14. Normality Test for PetCO2 Variable after Natural Logarithmic Transformation 
Variable  Shapiro-Wilk W  df  p 
Log- PetCO2   .918   144  .000 
 
The original un-transformed data were then split by their grouping variables and 
normality was tested again. The assumption of normality was met for all conditions except 
eupnea during phonation and hypercapnia during steady state (Table 8.15). Means and standard 
deviations for all conditions are reported in Table 8.16.  
72 
 
 
Table 8.15. Test of Normality for Breathing Condition Data as a function of Phonation 
Condition  Shapiro-Wilk W  df  p 
Eupnea steady state  .970   24  .661 
Eupnea phonation  .870   24  .005* 
Hypocapnia steady state .979   24  .877 
Hypocapnia phonation .973   24  .745 
Hypercapnia steady state .917   24  .050* 
Hypercapnia phonation .945   24  .212 
Note: * indicates significance at the .05 level. 
 
Because the largest standard deviation of the grouped variables (steady state and 
phonation) was not greater than twice the smallest standard deviation, the untransformed data 
(not the transformed data) were subjected to the Analysis of Variance (Moore, 2008).  
The interaction of breathing condition and phonation groups was significant (F[2,46] = 
8.165, p = .001, partial η2 = .262). In order to find the pattern of differences on PetCO2 values 
across breathing condition and phonation separately, the main effects for one variable were 
evaluated at individual levels of the other variable. Results were as follows.  
The simple main effect of breathing condition for phonated segments was significant: 
F(2,46) = 376.237, p < .001, partial η2 = .942. Pairwise comparisons using Bonferroni adjustment 
revealed significantly greater PetCO2 with phonation during hypercapnia than eupnea (p < .01) 
and hypocapnia (p < .01). The simple main effect of breathing condition for non-phonated steady 
state was also significant: F(2,46) = 1456.583, p < .001, partial η2 = .984. Again, pairwise 
comparisons using Bonferroni adjustment revealed significantly greater PetCO2 during non-
phonated steady-state in hypercapnia than eupnea (p < .01) and hypocapnia (p < .01). These 
results are consistent with physiologic expectations and confirm the success of the intended 
breathing perturbation. 
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In order to find the pattern of differences on phonation for each level of breathing 
condition, simple main effects of phonation at eupnea, hypocapnia, and hypercapnia were also 
performed. The simple main effect of phonation during eupnea was significant: F(1,23) = 
15.342, p = .001, partial η2 = .400. Similarly, the simple main effect of phonation during 
hypocapnia was also significant: F(1,23) = 65.081, p < .001, partial η2 = .739. Finally, the simple 
main effect of phonation at hypercapnia was also significant: F(1,23) = 19.433, p < .001, partial 
η2 = .458. The results revealed greater PetCO2 values during phonation than non-phonated steady 
state in each of the breathing conditions.  
The interaction between phonation and breathing condition was seen by 
disproportionately large increases in PetCO2 from steady state to phonation during hypocapnia (+ 
5mmHg) as compared to eupnea (+3 mmHg), with hypercapnia (+1 mmHg) showing the 
smallest increase (Figure 8.10). 
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Figure 8.10 Interaction of breathing condition and phonation. 
 
Table 8.16 displays the means, standard deviations and range of PetCO2 values for each 
breathing condition during steady state and phonation.  Figure 8.11 displays the raw PetCO2 
values for each observation in each condition (1 observation per breathing condition for both 
steady state and phonation, multiplied by 24 participants = 72 observations for steady state and 
72 for phonation).    
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Table 8.16. Mean, Standard Deviation, and Range of PetCO2 Values (mmHg) for Steady State 
and Phonated Portions of Each Breathing Condition 
Condition   Mean  SD  Range 
Eupnea steady state  32.72  2.72  26.53-37.46 
Eupnea phonation  35.38  4.10  22.53-40.95 
Hypocapnia steady state 18.61  1.89  14.28-22.46 
Hypocapnia phonation 23.48  4.02  16.00-31.23 
Hypercapnia steady state 50.16  1.50  47.10-52.50 
Hypercapnia phonation 51.84  2.52  47.74-56.25 
Note: all values in mmHg 
 
 
Figure 8.11. PetCO2 values (mmHg) for each observation during steady state respiration and 
phonation. 
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Figure 8.12. PetCO2 values (mmHg) during phonation for each participant in each breathing 
condition. 
Note: Eupnea PetCO2  = PetCO2 in the eupneic condition; Hypo PetCO2= PetCO2 in the 
hypocapnic condition; Hyper PetCO2= PetCO2 in the hypercapnic condition. 
 
 
8.3 SECONDARY OUTCOMES 
8.3.1 Vocal intensity. 
Due to a combination of factors including microphone positioning, noise produced by the gas 
cylinders, and overall trend towards lower than expected vocal intensities produced by the 
participants, dB SPL values were only available for 36/72 possible tokens. Of the 12 participants 
with complete intensity data sets, five had the greatest intensity in the hypocapnic condition, 
followed by hypercapnic and then eupneic; for 4 participants eupnea evoked the greatest 
intensity, followed by hypercapnia then hypocapnia; 2 participants had the greatest intensity in 
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hypercapnia followed by hypocapnia then eupnea; and one participant had the greatest intensity 
in the hypocapnic condition, then eupneic, and finally hypercapnic. 
A one-way within subjects Analysis of Variance (ANOVA) on dB SPL in each breathing 
condition was performed. The assumption of sphericity was met (Mauchly’s W = .822, X2(2) = 
1.955, p = .376), as was the assumption of normality (Table 8.17). 
 
Table 8.17. Test of Normality for dB SPL Values in Each Breathing Condition 
Condition   Shapiro-Wilk W  df  p 
dB SPL Eupnea  .908    12  .203 
dB SPL Hypocapnia  .949    12  .625 
dB SPL Hypercapnia  .958    12  .748 
 
 
No significant difference in dB SPL values among breathing conditions was found: F(2, 
22) = 3.367, p = .053, partial η2 = .234. Means and standard deviations of dB SPL values are 
shown in Table 8.18.  
 
Table 8.18. Mean, Standard Deviation, and Range of Corrected dB SPL Values for Each 
Breathing Condition 
Condition   Mean  SD  Range 
Eupnea                              63.57 dB         2.06                60.83-68.40 
Hypocapnia                       64.61 dB         3.43                57.86-72.01 
Hypercapnia                      64.41 dB         2.17                61.19-67.96 
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8.3.2 Fundamental frequency 
As with the dB SPL values, only 36/72 possible tokens were available for analysis of 
fundamental frequency (F0). Of the 12 participants with complete frequency data sets, 6 had the 
highest F0 during hypocapnia and the lowest in eupnea; 4 had the highest F0 in hypocapnia and 
the lowest in hypercapnia; 1 had the highest F0 in hypercapnia and the lowest in eupnea; and 
finally, 1 had the highest F0 in hypercapnia and the lowest in hypocapnia. More simply, the 
largest trend in F0 data appeared in hypocapnia, which produced the greatest F0 in 10/12 
participants.  
A within-subjects Analysis of Variance (ANOVA) was performed on fundamental 
frequency values as a function of breathing condition (eupnea, hypocapnia, hypercapnia). The 
assumption of sphericity was met (Mauchly’s W = .959, X2(2) = .416, p = .812), as was the 
assumption of normality (Table 8.19). 
 
Table 8.19. Test of Normality for F0 Data for Each Breathing Condition 
 
Despite distributional differences just noted, a significant difference in F0 values across 
breathing conditions was found F(2, 22) = 17.365, p < .001, partial η2 = .612. Pairwise 
comparisons revealed significantly higher F0 values during phonation in the hypocapnic 
condition (M = 229.74 Hz) than in hypercapnic (M = 218.29 Hz) or eupneic conditions (M = 
210.19 Hz); p = .029 and < .001 respectively. No significant difference was found in F0 between 
Condition   Shapiro-Wilk W  df  p 
F0 Eupnea   .948    12  .602 
F0 Hypocapnia   .939    12  .479 
F0 Hypercapnia  .951    12  .658 
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eupnea and hypercapnia (p = .076).  Figure 8.13 displays the available F0 data for each 
participant in each breathing condition. 
 
 
Figure 8.13. Available F0 data (Hz) for each participant in each breathing condition. 
 
8.3.3 Order effects 
The success of the counterbalanced and randomized design was tested using a Latin Square 
ANOVA. Six orders of condition presentation (eupnea, hypocapnia and hypercapnia) were 
possible, with four participants randomly assigned to each order. No significant order effects of 
Rlaw in the breathing conditions were found (p = .268). Order effects of PetCO2 were not tested, 
because each participant’s PetCO2 level was an experimental criteria for initiation of the 
phonation task in SA1a,b.  
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9.0  DISCUSSION 
9.1 PRIMARY OUTCOMES 
9.1.1 Laryngeal resistance  
The rather straightforward expectation that prompted this study was that when confronted with 
conflicting phonatory and respiratory needs, laryngeal resistance (Rlaw) would fluctuate in a 
direction that favors respiratory homeostasis, sacrificing its normal role in phonatory control. 
That is, the expectation was that Rlaw would be greatest in the hypo- as compared to the 
hypercapnic condition, thus assisting with a return to respiratory homeostatic baseline following 
perturbation.   Counter to expectations, no evidence whatsoever was found for such vulnerability 
in Rlaw, which remained remarkably stable.  Moreover, Rlaw remained within the range of normal 
values for healthy speakers under conditions of fairly substantial ventilatory disruptions. Not 
only did results of statistical analyses fail to reveal fluctuations in Rlaw under respiratory 
perturbation, inspection of individual data was also fruitless: 55% percent of participants showed 
greater Rlaw in the hypo- as compared to the hypercapnic condition, as hypothesized, whereas 
45% had the opposite response: greater Rlaw in hyper- as opposed to  hypocapnia.  Thus, even 
individual data provided no more clarity than a coin toss.  
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However, equally interestingly, attempts to examine the data more fully provided some 
insights. Separate analyses of airflow and estimated subglottic pressure (Psub) data, the 
component parameters of Rlaw, revealed that these parameters were modulated by respiratory 
condition.  Both airflow and Psub values increased robustly under the hypo- as compared with 
hypercapnic condition. Thus, phonatory control parameters were affected by the breathing 
conditions; they were simply affected in a way that maintained the constancy of Rlaw. Oddly, 
their modulation appeared paradoxical. It would seem that under conditions of hypocapnia 
(reduced CO2), simultaneous increases in airflow and Psub during phonation would serve to 
further expel CO2, thus exacerbating CO2 deprivation. More interesting for the present context, 
airflow and Psub increased in tandem in such a way as to maintain constancy in laryngeal 
resistance values. 
This observation leads to a crucial point for interpretation of the data.  Although the study 
was designed anticipating a demonstration of ventilatory supremacy over phonatory functions, 
the data imply it ended up being about another issue entirely: voice motor control. Specifically, 
results can be interpreted within a framework that considers voice motor control as part of a 
regulated system. A system is considered physiologically regulated if it detects perturbations and 
makes adaptive changes to achieve system goals  (Brobeck, 1965; Hammond, Warren, Mayo, & 
Zajac, 1999; Kim, Zajac, Warren, Mayo, & Essick, 1997; Warren, Dalston, Morr, Hairfield, & 
Smith, 1989; Warren, Morr, Rochet, & Dalston, 1989; Warren, Rochet, Dalston, & Mayo, 1992; 
Zajac, 1995).  
As a case in point, research on upper airway perturbations of the speech motor control 
system has found that despite induced oral or nasal pressure bleeds, human subjects maintain 
oral pressures at adequate levels for consonant production (Warren, Dalston, et al., 1989; 
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Warren, Morr, et al., 1989; Warren, et al., 1992). Pressures are maintained generally by a change 
in articulatory strategy (Zajac, 1995), sometimes at the expense of articulatory precision and 
intelligibility, as well as through increased respiratory effort or changes in constrictions 
elsewhere in the upper vocal tract (Hammond, et al., 1999; Kim, et al., 1997; Warren, Dalston, et 
al., 1989; Warren, et al., 1992).   
Similarly, in the present study, the system appeared resistant to threats to one of its 
apparent system goals, Rlaw.  Suggestions have been made that speakers make coordinated 
changes to maintain “aerodynamic integrity” (p. 566) in the face of perturbations (Warren, 
Dalston, et al., 1989). What remains largely unknown is to what change the speech (or voice) 
motor control system responds in order to adjust for intra-oral pressure drops or other potential 
perturbations. Stated differently, what is the goal that speech and voice regulating systems are 
attempting to meet?  In the speech literature, two competing hypotheses have been proposed; one 
view is that the goal is tactile; the other is that the goal is acoustic (Guenther, Hampson, & 
Johnson, 1998; Villacorta, Perkell, & Guenther, 2007; Warren, Dalston, et al., 1989; Warren, 
Morr, et al., 1989). These hypotheses, along with their potential relevance for the present 
findings, are discussed in turn next. 
Tactile goal hypothesis.  In support of a tactile goal hypothesis in speech motor control, 
evidence exists that speakers maintain oral air pressures during speech above 3cm H2O 
(necessary for consonant production) despite oral and nasal pressure bleeds (Warren, Dalston, et 
al., 1989; Warren, Morr, et al., 1989; Warren, et al., 1992). Furthermore, speakers are aware of a 
minimum change in oral pressure of 1cm H2O (Warren, Dalston, et al., 1989). Target pressures 
are maintained even when acoustic and articulatory accuracy are neglected (Warren, Morr, et al., 
1989). Across studies, an increase in oral airflow and respiratory effort have been observed as a 
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response to oral pressure leaks, and interpreted as one representation of an adaptation performed 
by the speech regulating system to maintain adequate intra-oral pressure for consonant 
production (Hammond, et al., 1999; Kim, et al., 1997; Warren, et al., 1992). Arguments are that 
tactile goals of this type are maintained via oral, nasal, pharyngeal, laryngeal, and tracheal 
mechanoreceptors, which provide feedback on changing pressure and airflow values 
(e.g.Warren, Dalston, et al., 1989). 
Extending the arguments to the case of aerodynamic resistance more broadly, of which 
pressure is one component, a close look at the literature on voice may reveal further support for 
the tactile goal hypothesis. Reports indicate phonatory laryngeal resistance (Rlaw) is maintained 
in healthy speakers across multiple time points and, more importantly for present purposes, also 
under varying auditory masking conditions (Grillo & Verdolini, 2007; Leeper & Graves, 1984). 
Specifically, with and without auditory masking, which effectively removes acoustic feedback 
for voice, Rlaw is maintained as normal. Results from the current study demonstrating relatively 
stable Rlaw values during respiratory perturbations – moreover under conditions of substantial 
ambient noise -- may lend support to the idea that not only pressure, but also the combination of 
pressure and flow – Rlaw – represent fairly immutable, tactile-based control parameters in voice 
production. 
Auditory goal hypothesis.  Of course, evidence exists that acoustic feedback is necessary 
for normal voice and speech production. The literature demonstrating inarticulate speech and 
abnormal vocal quality in congenitally deaf individuals supports the need for auditory input to 
acquire normal, acceptable speech and voice communication in the long term. Clearly, an 
acoustic goal for communication exists. However, the foregoing argument posits that an acoustic 
goal is not the only – or most salient - goal (Warren, et al., 1992). Furthermore, most regulating 
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systems attempt to preserve more than one component part of system functioning in order to 
achieve that system’s goal (Kim, et al., 1997). In contrast to arguments for a tactile goal in 
speech and voice, multiple authors have hypothesized that the goal of the speech motor control 
system is an invariant acoustic one (Guenther & Gjaja, 1996; Guenther, et al., 1998). One 
example of an acoustic goal theory lies with vowel production, in which it is argued that tactile 
feedback references are not available, yet vowels are easily produced normally in connected 
speech. Supporters agree that tactile feedback explains adequate, consistent consonant but not 
vowel production (Guenther, et al., 1998; Villacorta, et al., 2007). In addition, many speech 
sounds can be produced with a variety of oral-pharyngeal configurations (such as the /r/ 
phoneme) and still be perceived auditorily as normal (Guenther, et al., 1998). In order for the 
nervous system to respond to a production error, an efferent signal detecting the error must be 
received so that a motor correction can be made. This sequence must occur rapidly online for 
normal speech to continue. Proponents of the acoustic goal theory argue that auditory perceptual 
feedback is constantly available for all speech sounds, whereas information on location of oral-
pharyngeal-laryngeal constriction, including pressure and airflow information, is not equally 
available for consonants and vowels and therefore cannot be the primary means by which speech 
is regulated (Guenther, et al., 1998). 
Although these arguments are appealing, their relevance for present study is unclear.  As 
noted, ambient noise was substantial in the study, and yet not only Rlaw, but also output intensity 
appeared invariant across conditions.  The conclusion is that at least in this study, Rlaw was not 
somehow acoustically regulated, and must have been regulated instead by some other sense 
domain – most logically the tactile sense. 
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9.1.1.1 Respiratory kinematics 
 
Additional possibilities to explain the consistent Rlaw results may lie with respiratory 
kinematics. Respiratory effort, that is, ventilation, increased in both hypo- and hypercapnic 
conditions in the current study. Specifically, the hypocapnic condition required participants to 
hyperventilate in order to expire enough CO2 to achieve and maintain hypocapnia. The 
hypercapnic condition caused an increase in minute ventilation on average 12 L/minute over the 
eupneic condition. This observation is similar to minute ventilation increases of 18 L/minute 
reported in the literature on speech breathing in hypercapnia (Bailey & Hoit, 2002). Therefore, 
both experimental conditions- hypocapnia and hypercapnia- required or resulted in 
hyperventilation. 
Upper airway resistance during breathing is affected by respiratory frequency and lung 
volume. First, as ventilation increases, upper airway resistance during breathing decreases 
(England & Bartlett, 1982; England, Bartlett, & Daubenspeck, 1982; Kuna, Insalaco, et al., 1993; 
Shindoh, et al., 1985). Hyperventilation has shown to increase laryngeal abductor muscle 
activity, thereby increasing glottal area (and decreasing resistance) during breathing (Savard, et 
al., 1993). Relevant to the present study, an increase in ventilation is also observed during speech 
breathing as compared to quiet breathing (Hoit & Lohmeier, 2000).  
Second, as lung volumes increase, laryngeal resistance during breathing also decreases 
(Hoit, et al., 2007; Shindoh, et al., 1985). Hypercapnia can cause an increase in functional 
residual capacity, thereby increasing lung volume, and, decreasing laryngeal resistance during 
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breathing, and, by extension, phonation (England, Bartlett, & Knuth, 1982; Iwarsson, et al., 
1998; Lowell, Barkmeier-Kraemer, Hoit, & Story, 2008; Savard, et al., 1993).  
Finally, hyperventilation can override the increase in laryngeal adductor activity expected 
in hypocapnia, therefore causing a decrease, not increase, in laryngeal resistance during 
breathing as expected (Bartlett & Knuth, 1984). The rapid breathing in both the hyper- and 
hypocapnic conditions may have counteracted the expected Rlaw responses to the conditions, 
effectively eliminating the hypothesized effects of the CO2 manipulations (England, et al., 1985). 
In other words, the effects of hyperventilation on Rlaw in conditions of hypercapnia and 
hypocapnia in the current study may have been strong enough to overcome expected effects of 
the CO2 changes, resulting in statistically equivalent Rlaw results (Bartlett & Knuth, 1984; 
Savard, et al., 1993).   
Perturbation studies have established that the speech production system exhibits motor 
equivalence by using new articulatory configurations to meet a communication goal when the 
default configuration is precluded by a perturbation (Guenther, et al., 1998). In this view, 
respiratory kinematic changes may have occurred as an adaptation to the experimental condition 
in order to keep phonatory resistance consistent. Past studies on speech breathing in healthy 
participants subjected to conditions of increased CO2 have demonstrated respiratory kinematic 
changes in the experimental condition. Specifically, lung volumes were larger and chest wall 
movements bigger and faster in the high CO2 condition than in room air breathing (Bailey & 
Hoit, 2002). However, these volume and kinematic changes were somewhat attenuated by the act 
of speaking. The authors concluded that “the average ventilatory response of our subjects to high 
CO2 was substantially smaller during speaking than during breathing. This…supports the idea 
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that speaking ‘overrides’ to some extent the metabolic control of breathing.” (Bailey & Hoit, 
2002, p. 97).  
Other authors have also found that respiratory strategies, such as lung volumes utilized 
for phonation, differ in individuals with and without voice problems, while direct laryngeal 
factors, such as vocal fold adduction, remain constant between those with and without voice 
problems (Lowell, et al., 2008). The current study lends support to this theory of a 
communication “override,” by demonstrating stable Rlaw despite substantial respiratory 
perturbation. It should also be noted that in both the current study and the one by Lowell and 
colleagues, healthy participants were involved. It may be that laryngeal and respiratory variables 
remain constant only up to a certain level of perturbation, as in the case of respiratory disease, 
which these experimental manipulations did not fully replicate. Future studies will measure lung 
volume and respiratory kinematic variables that may have been affected by the experimental 
conditions.  
9.1.2 End-tidal Carbon Dioxide 
The second aim of the current study was to examine the effects of phonation on PetCO2. 
Significant main effects of phonation and breathing condition were found, revealing that 
participants achieved and maintained the PetCO2 target values for each breathing condition, 
regardless of the presence or absence of phonation. Examination of the non-phonated steady-
state PetCO2 means confirmed that participants achieved the desired breathing condition before 
the initiation of phonation (eupnea M = 34.05 mmHg, hypocapnia M = 21.05 mmHg, 
hypercapnia M = 50.99 mmHg). The target PetCO2 for the hypercapnic condition was 50mmHg, 
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which was the overall mean for the participants. The target PetCO2 for the hypocapnic condition 
was 50% of the baseline +/- 2 mmHg. All but three participants met their individual hypocapnic 
target PetCO2. These three participants all had lower than average baseline PetCO2 values (33.9 
mmHg, 27.5 mmHg, 29.8 mmHg respectively) and lower than average baseline minute volumes 
(8 L/min, 5.25 L/min, and 7.8 L/min respectively). These values indicated that at baseline these 
participants were hypoventilating, making extreme experimental hypocapnia less possible for 
them than for the other 21 participants.  However, their hypocapnic PetCO2 values were still 
within the typical range for hypocapnia and were therefore retained in the final data set.   
In all three breathing conditions, the act of phonation resulted in a significant increase in 
PetCO2. This increase makes physiologic sense. During steady state, the vocal folds are abducted 
to allow flow of gas into and out of the lungs.  During phonation, the vocal folds adduct, causing 
a momentary slow-down of expiration and retention of gas, leading to an increase in arterial 
CO2, as measured by PetCO2. However, the act of phonation was not strong enough to offset 
effects of the experimental conditions (eupnea, hypocapnia, and hypercapnia), which persisted 
with distinctly different PetCO2 values even during phonation. This result supports findings from 
past research, which have shown PetCO2 values to be greater during speaking than during rest 
breathing under normal breathing conditions (Russell, et al., 1998). 
 In the current study, a significant interaction between the two variables was found, so 
that PetCO2 increased more during phonation for the hypocapnic condition, followed by eupneic, 
and finally, hypercapnic condition.  This interaction lends support for the original hypothesis- 
that phonation would assist in returning the system to homeostatic baseline for the hypocapnic 
condition. During phonation in hypocapnia, more CO2 was retained than during phonation during 
the other two conditions, as would be expected in a physiologic system working towards the goal 
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of return to normocapnic levels. Contrary to the original hypothesis was the maintenance of Rlaw 
even in hypercapnia, which prevented the expulsion of CO2 to return to baseline.  
9.1.3 Intensity and fundamental frequency 
Intensity, like Rlaw in the current study, remained constant in each of the experimental conditions. 
This finding lends further support to the critical relevance of tactile feedback for control of 
phonation in a goal-oriented system. In the present experiment, the ambient noise in the 
experimental room changed with each condition due to sound generated by delivery of the 
experimental gases. In addition, participants wore a facemask for all trials, therefore distorting 
the acoustic output perceived through air conduction. Despite these changes in acoustic 
environment, no significant difference in intensity was found across the conditions, indicating 
that participants maintained intensity as they did Rlaw.  
Interpretation of the fundamental frequency results is less clear. Fundamental frequency 
(F0) was greatest in the hypocapnic condition than the other two conditions. In that condition, 
both airflow and Psub were increased. The increase in Psub that occurs with vocal fold lengthening 
makes Psub a secondary mechanism by which F0 increases (Titze, 1994). Increases in airflow 
have also been shown to increase F0, though not systematically (Holmberg, et al., 1988).  
Phonatory laryngeal airway resistance has also shown to be insensitive to changes in F0, as was 
the case in the current study (Leeper & Graves, 1984). The significant increase in Psub and 
airflow in the hypocapnic condition may be responsible for the increase in F0 in that condition 
above eupnea and hypercapnia. 
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9.1.3.1 Comment on methods 
Two aspects of the methods may have influenced results and deserve mention here. First, 
participants were trained in the voice task the day before the experiment, and a review was 
conducted immediately prior to the start of the experiment in order to guarantee proper 
production of the task and to avoid variations in Rlaw due to unfamiliarity (Dastolfo, 2011; Helou 
& Solomon, 2011). However, this practice may have caused unwanted learning effects. In other 
words, if participants were too well-trained in the task, they may have worked to produce it as 
closely to the learned task as possible, not allowing for compensations that might have been 
naturally triggered as a result of the experimental exposures. That is, the act of practice may have 
caused the coordination of Rlaw in the specific experimental voice task to stabilize (Kim, et al., 
1997; Zanone & Kelso, 1997). In support of this claim, a study of speech breathing changes 
induced by hypercapnia found that participants maintained “natural” speech despite substantial 
dyspnea and respiratory kinematic changes caused by the hypercapnia (Hoit, et al., 2007). 
Participants adhered to these speech goals despite their having received no specific instructions 
to do so.  However, in the present study, there was no good option to minimize the potential 
learning effect.  If subjects had not been pre-trained in the phonation task prior to data collection, 
learning factors could have introduced unwanted effects in the data.  
The second methodologic issue that could have influenced results involved the time 
participants spent phonating in each experimental breathing condition. The phonatory tasks were 
quite short (no more than 3 seconds per phonated segment of five /pa/ syllables, with breaths 
allowed between segments). Therefore, the upper airway could have delayed altering laryngeal 
resistance to satisfy the physiologic goal to return to respiratory homeostasis for the short period 
of experimental time in phonation. In this sense, the higher level phonatory goal (production of a 
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trained syllable string) was able, in the short term, to “win” over the basic physiologic goal of 
maintaining ventilatory homeostasis. However, one argument against time as a limiting factor 
can be found in the laryngeal resistance in breathing literature, which has shown the glottal 
response to altered CO2 to occur immediately (England, Bartlett, & Knuth, 1982). However, past 
research on speech breathing in chemically-induced dyspnea utilized speaking tasks of 7-10 
minutes in duration (Hoit, et al., 2007; Hoit & Lohmeier, 2000; Russell, et al., 1998). 
Participants in those studies, as in the current study, reported subjective complaints of dyspnea. 
Although the prior studies did not examine laryngeal effects of dyspnea, it remains possible that 
the time spent in the vocal task in the current study was not sufficiently long to observe the 
laryngeal effects of hypo- and hypercapnia.  
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10.0  FUTURE DIRECTIONS 
The current study demonstrated that in healthy participants, phonatory laryngeal resistance is 
maintained despite manipulations of inspired gas concentrations causing significant increases 
and decreases in expired carbon dioxide (CO2) levels. The study also showed that phonation 
causes a consistent and significant increase in CO2 in expired breaths compared to non-phonated 
expired breaths. In sum, data from the study are consistent with the proposal that the vocal 
control system is a regulated system, capable of maintaining normal phonatory laryngeal 
resistance values despite significant respiratory perturbations – moreover suggesting that such 
resistance may be a critical control parameter in voice production. Results of the current study 
also support past literature demonstrating that phonation causes a significant increase in PetCO2. 
The study validated the safety and efficacy of a 7% CO2 inhalation challenge for achieving 
hypercapnia and inducing dyspnea, as well as guided hyperventilation for achieving hypocapnia, 
in healthy participants. 
The apparent stability of phonatory laryngeal resistance despite changes in minute 
ventilation, and end-tidal PCO2 invites questions about the perturbability of the phonatory 
system. Obviously, voice problems occur. They are, in fact, not uncommon. Estimates show that 
3-9% of the population experience voice problems at any given point in time (Verdolini & 
Ramig, 2001). Furthermore, up to 70% of voice clinic caseloads are comprised of voice 
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problems without obvious structural or neurologic cause (Angsuwarangsee & Morrison, 2002; 
Roy, 2003, 2010). These voice problems, called Primary Muscle Tension Dysphonia (MTD-1), 
are often thought to be due to a dyscoordination between breathing and voicing (Hixon & Hoit, 
2005; Hixon & Putnam, 1983; Iwarsson, et al., 1998; Morrison, 1997; Morrison & Rammage, 
1993). In addition, people with MTD-1 often complain of dyspnea while speaking (Nguyen, et 
al., 2009). The current study hypothesized that one cause of MTD-1 may be a laryngeal response 
to respiratory gas fluctuations. Specifically, the hypothesis stated that phonatory laryngeal 
airway resistance would change in a similar way as non-phonatory (e.g. respiratory) upper 
airway resistance as a result of hyper- and hypocapnia. This hypothesis was not supported by the 
results in healthy participants. The question remains then as to what mechanisms facilitate the 
dyscoordinated breathing in individuals with voice problems (namely, MTD-1), and why 
individuals with lower airway disease complain of more voice problems than individuals without 
lower airway disease (Carding, et al., 2006; Cohen, 2010; Schalen, et al., 1992). Some possible 
options for future research aimed at exploring these issues are examined next. 
First, the original hypothesis of the current study ought to be re-tested with some 
methodologic changes. Phonatory laryngeal airway resistance (Rlaw) may in fact be susceptible to 
changes in blood gas concentrations over time. To that end, one future study would investigate 
the effects of hyper- and hypocapnia on Rlaw using longer reading passages prior to calculation of 
resistance, in order to challenge the phonatory mechanism further. Such a study would use 
methods already vetted in the speech breathing literature (Hoit, et al., 2007; Russell, et al., 1998) 
coupled with the methods used for achieving hyper- and hypocapnia in the current study.  
Second, the experimental conditions in the current study caused changes in minute 
ventilation (a product of tidal volume and respiratory rate). Namely, the hypocapnic condition 
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resulted in an average increase in 43 L/min, and the hypercapnic condition caused an increase of 
12 L/min compared to the eupneic condition. Lung volume, although not explicitly measured in 
the current study, and respiratory rate affect vocal fold behavior both during phonation and rest 
breathing (Bailey & Hoit, 2002; Brancatisano, et al., 1991; Brancatisano, et al., 1983; Hoit, 
Solomon, & Hixon, 1993; Insalaco, Kuna, Cibella, & Villeponteaux, 1990; Iwarsson, et al., 
1998). In addition, laryngeal behavior has shown to impact lower airway function, especially 
with regard to lung volumes (Hixon & Hoit, 2005; Lowell, et al., 2008; Sapienza & 
Stathopoulos, 1994). Despite the changes to minute ventilation in the current study, Rlaw was 
unchanged in the experimental conditions compared to baseline. Future studies will examine the 
changes in specific lung volumes and capacities (e.g., tidal volume, functional residual capacity) 
during phonation in hypo- and hypercapnic challenges. Studies will also measure respiratory 
kinematic adaptations to the challenges- namely the contributions of the rib cage and abdomen to 
the overall breathing pattern. Measurement of these values will further elucidate the adaptations 
the entire phonatory system makes in response to respiratory perturbations. This knowledge may 
also shed further light on how respiratory kinematic changes influence voice production and 
participate in regulation of the phonatory system.  
Third, in addition to hypothesized chest wall kinematic pattern changes, laryngeal muscle 
activation may have changed as a result of the experimental conditions. In accordance with both 
acoustic and tactile goals of vocal motor control, phonatory stability may have been maintained 
through adjustments in not only the respiratory system, but the glottal voice source as well 
(Guenther, 2012). It was hypothesized that participant hyperventilation overrode the expected 
increase in adductor muscle activity in hypocapnia and abductor activity in hypercapnia in the 
current study (Bartlett & Knuth, 1984; Savard, et al., 1993). Laryngeal electromyography of the 
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major ab- and adductor muscles may reveal different muscle activation patterns among the 
experimental conditions.  
Fourth, one major difference between the experimental conditions in the current study 
and “real life” is that healthy individuals without lung disease were enrolled as participants. It is 
realistic to hypothesize that presence of lung disease, and the compensations that occur to the 
respiratory system over time as a result of lung disease, may cause changes to respiratory 
mechanics, which influence voice, laryngeal function during phonation; or both. For example, in 
lung disease, an increased reliance on accessory muscles of respiration is observed. This pattern 
of breathing has shown to impact phonation by contributing to a harsh and strained voice quality, 
subjective reports of increased vocal effort and phonatory discomfort, elevated laryngeal position 
in the neck, and alterations in length and depth of inspiration that can impact, along with vocal 
quality, utterance length, and vocal loudness (Hixon & Hoit, 2005; Hixon & Putnam, 1983; Hoit, 
et al., 1993; Iwarsson, 2001; Mathieson et al., 2009; Stone, 1993). Future studies will investigate 
the effects of chronic lung disease on phonation. 
Finally, future studies might be specifically designed to test hypotheses about the voice 
motor control system in terms of tactile or auditory goals.  Those studies could provide further 
depth to the experimental framework for studies on interactions between voice and respiratory 
functions. 
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APPENDIX A. 
VHI-10 AND RSI QUESTIONNAIRES 
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APPENDIX B. 
CONSENT FORM 
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Clark Rosen, M.D., FACS 
Director, University of Pittsburgh Voice Center 
UPMC Mercy Hospital 
Building D Suite 2100 
1400 Locust St., Pittsburgh, PA 15219 
Telephone: 412-232-7464    
 
Why is this research being done? 
The vocal folds are located in the throat and are responsible for the control of gas flow into and out of the 
lungs for breathing and for voice production.  The vocal folds allow more or less air to enter and leave the 
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lungs to help rid the body of too much carbon dioxide, or allow more oxygen to come into the body. 
Abnormal levels of carbon dioxide occur in a wide-range of respiratory disorders, psychological 
disorders, and neuromuscular disorders. The air we exhale also vibrates the vocal folds to produce sound 
for speech. Breathing abnormalities are blamed for many voice problems, specifically voice problems that 
affect women more than men. It is unknown how breathing disorders may affect how the vocal folds 
produce sound, and possibly lead to the development of voice problems. This research is investigating 
how changes in the levels of carbon dioxide in the body impact how the vocal folds (cords) function 
during speech in females. Specifically, we are investigating how the vocal folds (cords) move and 
produce sound when speaking after breathing air containing changing levels of carbon dioxide. 
 
Who is being asked to take part in this research study? 
English speaking females between the ages of 18-45, without a history of voice problems (voice 
disturbance lasting for greater than 2 weeks, or recurring greater than 3 times per year) including any 
voice treatment; no history of respiratory disorders including asthma, chronic obstructive pulmonary 
disease (including chronic bronchitis and emphysema), obstructive sleep apnea (OSA); no history of 
psychological disorders including depression, anxiety, panic disorder; no history of vocal training 
(“training” is defined as any private study in vocal performance); no history of any medication use that 
might affect voice or breathing for a 2-week period before the protocol; and not currently pregnant (as 
confirmed by a urine pregnancy test at the time of screening), non-menopausal, and not a smoker.  If you 
are eligible to participate, you will then have a qualifying exam to see if you can continue to take part in 
the study. Approximately 24 people will participate in this study. 
 
What procedures will be performed for research purposes? 
If you decide to take part in this research study, you will undergo the following procedures. 
 
Screening Procedures: 
Procedures to determine if you are eligible to take part in a research study are called “screening 
procedures.”  For this research study, screening procedures include answering demographic (name, age, 
contact information), medical, and voice history questions.  All women of child-bearing potential will be 
given a urine pregnancy test.  You will complete two questionnaires about your voice. A recording of 
your voice will be done and a speech-language pathologist who specializes in voice will judge if your 
voice sounds normal or not based on the recording.  Your hearing will also be tested.  A doctor that 
specializes in ears, noses, and throats will examine your nasal passage and throat with either a flexible 
scope, which is a lighted optical instrument passed through the nose (flexible scope) to get a deep look 
inside the body and examine areas such as the throat.  Before the flexible scope is passed, about three cc 
(approximately ½ teaspoon) of a FDA (Food and Drug Administration) approved topical aesthetic 
(numbing medicine) (4% atomized Cetacaine) will be sprayed into your nose and throat, to increase your 
comfort. The pictures of your throat will be videotaped and saved.  A test of your breathing will also be 
completed by a speech-language pathologist.  For this test, you will breathe into a mouthpiece at your 
normal rate of breathing, and then you will take two big, deep breaths.  These screening procedures will 
take about 30-45 minutes of your time and will take place at the University of Pittsburgh Voice Center at 
UPMC Mercy Hospital.    
 
Pre-experimental training: 
If you are eligible to continue in the study based on the results of the screening, you will be trained in the 
voice procedures.  You will be trained to make specific sounds while your voice is being recorded.  You 
will produce these sounds during the experiment on the following day. 
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Experimental Procedures: 
The experiment will take place the day following the screening procedures at UPMC Kauffman Building 
in Oakland. 
For all procedures, you will wear a facemask over your nose and mouth.  First, we will take breathing 
measurements as you breathe normally into the mask.  This will last approximately 15 minutes. Then, you 
will breathe in three different air mixtures- one mixture will have greater than usual amounts of carbon 
dioxide, another mixture has less than usual carbon dioxide, and the third mixture will be normal air.  
These mixtures may make you breathe faster.  You may also feel light-headed or panicky.  For each air 
mixture, you will produce the sounds that you were trained to make during the pre-experimental training.  
Each breathing trial will last approximately 5 minutes.  You will have a minimum of a 15 minute break 
between each breathing trial.  
 
For experimental testing purposes we will be collecting data on your breathing rate, levels of carbon 
dioxide and oxygen in the air you exhale, heart rate, pitch of your voice, loudness of your voice, and the 
air pressure and airflow you generate to create voice.  
 
The entire study will occur on 2 consecutive days and last approximately 3 hours total time. 
 
What are the possible risks, side effects, and discomforts of this research study? 
Risks associated with the examination of your throat include discomfort to the nasal passage with the 
flexible scope and nosebleed (rare).  These risks will be minimized with the use of local anesthesia 
(numbing medicine) as described above. The risks of the numbing medicine include (rare) 
hypersensitivity, including contact dermatitis characterized by redness and itching. However this occurs 
most commonly in patients following prolonged self-medication (rare). The risks associated with the 
breathing test are shortness of breath and lightheadedness (mild-moderate <1%).  These risks will be 
minimized with training prior to the testing procedure, as well as allowing you as much time as needed to 
rest after the test. 
  
The risks associated with the experimental breathing conditions (breathing in more or less carbon dioxide 
than usual) are dizziness, headaches, chest tightness, tingling in your fingers and toes, and, panic attack 
(rare).  There is also a risk of vaso-vagal reaction.  This reaction is when an individual experiences 
symptoms such as lightheadedness, nausea, the feeling of being extremely hot (accompanied by 
sweating), ringing in the ears (tinnitus), uncomfortable feeling in the heart, fuzzy thoughts, a slight 
inability to speak/form words (sometimes combined with mild stuttering), weakness and visual 
disturbances such as lights seeming too bright, fuzzy or tunnel vision, and sometimes a feeling of 
nervousness can occur as well. In rare instances, fainting or loss of consciousness can occur. This risk is 
rare. 
The risks are the same for breathing in more carbon dioxide (hypercapnia) and less carbon dioxide 
(hypocapnia) but may be more severe for the hypercapnia condition. These risks will be minimized by 
monitoring your vital signs (heart rate, oxygen saturation).  In addition, all procedures are conducted in a 
medical setting with a physician in the vicinity and access to a medical crash cart. You are also allowed to 
stop the procedure at any time without any negative consequences. An additional risk of breach of 
confidentiality also exists. That is, in very rare cases, people not associated with this research study may 
inadvertently see your identifiable research results.  We will do everything in our power to prevent this 
from happening by keeping all research records in locked files, and identify all videotaping information 
by a research record number, rather than by your name or social security number.  The codebook 
containing your name and number will be kept secure by the Study Coordinator.  
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As with any experimental procedure, there may be adverse events or side effects that are currently 
unknown, and certain of these unknown risks could be permanent, severe or life-threatening. 
 
What are the possible benefits from taking part in this study? 
You will not gain any personal benefit from participation in the study.  The risks of the screening 
procedures are no different than those experienced during routine medical examinations by an ear, nose, 
and throat doctor and lung doctor.   
 
Will my insurance provider or I be charged for the costs of any procedures performed as part of this 
research study? 
You will not be charged for the costs of any of the procedures performed for the purpose of this research 
study.  The costs of these research procedures will be paid for by the study. You will be compensated for 
parking.  
 
Will I be paid if I take part in this research study? 
You will be paid $50 compensation for completing this research study. If you complete the screening 
procedures and are deemed ineligible, or choose not to participate, you will be compensated $10. 
 
Who will pay if I am injured as a result of taking part in this study? 
University of Pittsburgh researchers and their associates who provide services at the University of 
Pittsburgh Medical Center (UPMC) recognize the importance of your voluntary participation in their 
research studies.  These individuals and their staffs will make reasonable efforts to minimize, control, and 
treat any injuries that may arise as a result of this research.  If you believe that you are injured as a result 
of the research procedures being performed, please contact immediately the Principal Investigator or one 
of the co-investigators listed on the first page of this form. 
 
Emergency medical treatment for injuries solely and directly related to your participation in this research 
study will be provided to you by the hospitals of the UPMC.  It is possible that the UPMC may bill your 
insurance provider for the costs of this emergency treatment, but none of these costs will be charged 
directly to you.  If your research-related injury requires medical care beyond this emergency treatment, 
you will be responsible for the costs of this follow-up care unless otherwise specifically stated below.  
There is no plan for monetary compensation. You do not, however, waive any legal rights by signing this 
form. 
 
Who will know about my participation in this research study? 
Any information about you obtained from this research will be kept as confidential (private) as possible.  
All records related to your involvement in this research study will be stored in a locked file cabinet.  Your 
identity on these records will be indicated by a code rather than by your name, and the information 
linking these codes with your identity will be kept separate from the research records.  You will not be 
identified by name in any publication of the research results unless you sign a separate consent form 
giving your permission (release). 
 
Who will have access to identifiable information related to my participation in this research study? 
In addition to the investigators listed on the first page of this authorization (consent) form and their 
research staff, the following individuals will or may have access to identifiable information related to 
your participation in this research study:  
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Authorized representatives of the University of Pittsburgh Research Conduct and Compliance Office may 
review your identifiable research information for the purpose of monitoring the appropriate conduct of 
this research study.  
 
In unusual cases, the investigators may be required to release identifiable information related to your 
participation in this research study in response to an order from a court of law.  If the investigators learn 
that you or someone with whom you are involved is in serious danger or potential harm, they will need to 
inform, as required by Pennsylvania law, the appropriate agencies. 
 
For how long will the investigators be permitted to use and disclose identifiable information related to 
my participation in this research study? 
It is a University of Pittsburgh policy that all research records be maintained following final reporting or 
publication of a project, although records can be kept indefinitely.  The investigators may continue to use 
and disclose, for the purposes described above, identifiable information related to your participation in 
this research study for a minimum of 7 years and for as long (indefinite) as it may take to complete this 
research study. 
 
Is my participation in this research study voluntary? 
Your participation in this research study is completely voluntary.  Whether or not you provide your 
consent for participation in this research study will have no effect on your current or future relationship 
with the University of Pittsburgh.  Whether or not you provide your consent for participation in this 
research study will have no effect on your current or future medical care at a UPMC hospital or affiliated 
health care provider or your current or future relationship with a health care insurance provider. 
 
May I withdraw, at a future date, my consent for participation in this research study? 
You may withdraw, at any time, your consent for participation in this research study, to include the use 
and disclosure of your identifiable information for the purposes described above.  Any identifiable 
research information recorded for, or resulting from, your participation in this research study prior to the 
date that you formally withdrew your consent may continue to be used and disclosed by the investigators 
for the purposes described above. 
 
To formally withdraw your consent for participation in this research study you should provide a written 
and dated notice of this decision to the principal investigator of this research study at the address listed on 
the first page of this form. 
 
Your decision to withdraw your consent for participation in this research study will have no effect on 
your current or future relationship with the University of Pittsburgh.  Your decision to withdraw your 
consent for participation in this research study will have no effect on your current or future medical care 
at a UPMC hospital or affiliated health care provider or your current or future relationship with a health 
care insurance provider. 
  
 
May I be withdrawn from the study for any reason? 
If you are unable to complete any of the procedures required for participation in the study, you may be 
withdrawn.  If you experience an adverse event to the experimental procedures, you will be withdrawn 
from study participation. 
 
 
 
103 
 
VOLUNTARY CONSENT 
 
All of the above has been explained to me and all of my current questions have been answered.  I 
understand that I am encouraged to ask questions about any aspect of this research study during the 
course of this study, and that such future questions will be answered by the researchers listed on the first 
page of this form.   
 
Any questions, which I have about my rights as a research participant, will be answered by the Human 
Subject Protection Advocate of the IRB Office, University of Pittsburgh (1-866-212-2668).  
 
By signing this form, I agree to participate in this research study.  A copy of this consent form will be 
given to me. 
 
________________________________              __________________ 
Printed Name of Participant     Date 
 
________________________________    
Participant’s Signature      
 
 
CERTIFICATION of INFORMED CONSENT 
 
I certify that I have explained the nature and purpose of this research study to the above-named 
individual(s), and I have discussed the potential benefits and possible risks of study participation. Any 
questions the individual(s) have about this study have been answered, and we will always be available to 
address future questions as they arise.  I further certify that no research component of this protocol was 
begun until after this consent form was signed. 
___________________________________    ________________________ 
Printed Name of Person Obtaining Consent       Role in Research Study 
__________________________________    _________________ 
Signature of Person Obtaining Consent          Date 
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APPENDIX C.  
EMAIL/PHONE SCRIPT FOR ELIGIBILITY 
Hello! 
Thank you for your interest in participating in our study, The Effects of Hyper- and Hypocapnia 
on Phonatory Laryngeal Resistance.  In this study we will investigate the effects of different 
types of gas concentrations on voice.  In the study, participants will be asked to breathe different 
gas mixtures, and then produce different sounds.  The study will take place on 2 consecutive 
days at 2 locations- UPMC Mercy Hospital in downtown Pittsburgh, and UPMC Kauffman 
Building in Oakland.  The study will take approximately 3 hours of total time.  You may be 
compensated up to $50 for your participation. 
 
Let me tell you a bit about the study procedures. 
 
First, as part of the study, participants will undergo a screening.  This screening will first involve 
you answering a series of questions here today.  If you are still eligible to participate based on 
your answers, we will schedule an in-clinic screening.  That screening will take place at the 
UPMC Voice Center located in UPMC Mercy Hospital in downtown Pittsburgh.  At that 
screening, a specialized ear, nose, and throat physician will assess if you tolerate passage of a 
flexible endoscope through your nose in order to visualize your vocal folds.  You will also 
undergo a breathing test to make sure your lungs work normally.   
 
If you are still interested in participating, let’s begin with the eligibility questions. 
 
1. Are you female between the ages of 18-45? 
2. Have you ever had a voice problem that lasted for longer than 2 weeks, or 
recurred more than 3 times in one year? 
3. Have you ever had any voice therapy? 
4. Have you ever had a respiratory disorder including asthma, COPD, emphysema, 
or obstructive sleep apnea? 
5. Have you ever had any vocal training consisting of greater than one year of 
private study in vocal performance? 
6. Do you take any medications which may affect voice? 
7. Are you pregnant? 
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If ineligible: Thank you very much for your time in answering our questions.  Unfortunately, you 
are not eligible to participate in this study. 
 
If eligible:  Thank you very much for your time in answering our questions.  Based on your 
answers, you are eligible to participate in this study!  Now we need to schedule your in-clinic 
screening at UPMC Mercy Hospital.  If you pass that screening, you will go on to complete the 
experiment at the UPMC Kauffman Building in Oakland.  May we also schedule that 
appointment now? 
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APPENDIX D  
SCREENING FORM 
Subject ID:______________________    Date:_______________ 
Consent:_____________ 
 
Self-Report Questions: 
Age 18-45?______________   History of Respiratory Disorder?_____________ 
Smoker?:________________   History of voice training?___________________ 
History of Psychological Disorder?_______ History of a voice problem?_________________ 
English Speaking?_______________ 
 
Pregnancy test: ____________________ 
 
Hearing Screen:  30dB @: 500 Hz:_________  1000 Hz:______________ 
    1500 Hz:__________  1500 Hz:______________ 
 
Cape-V score <20:___________________ 
 
Laryngeal Exam: _____________________ 
 
Pulmonary function test: ___________________ 
 
Eligible? ______________________________ 
 
Experimental Date: _____________________ 
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APPENDIX E  
SUBJECT INFORMATION FORM 
 
Map of Oakland indicating the Kauffman Building- 3471 5th Ave. 
Please go to room 1211 (COPD/Emphysema Research Lab) 
Please wear a loose fitting t-shirt so we may attach the heart-rate monitor to your sides. 
Please do not wear earrings or fingernail polish. 
Time:_______________  Date:___________________________ 
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